Bibliography
Published online by Cambridge University Press: 04 August 2010
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Incentives for Global Public HealthPatent Law and Access to Essential Medicines, pp. 425 - 485Publisher: Cambridge University PressPrint publication year: 2010
References
, ‘Intellectual Property Provisions of Bilateral and Regional Trade Agreements in Light of U.S. Federal Law’ (2006) United Nations Conference on Trade and Development – International Centre for Trade and Sustainable Development Issue Paper No 12, www.ictsd.org/pubs/index.htm at 27 January 2009.Google Scholar
‘Intellectual Property Rights in a Global Trade Framework: IP Trends in Developing Countries’ (2004) 98 American Society of International Law and Procedure95.Google Scholar
‘Managing the Hydra: The Herculean Task of Ensuring Access to Essential Medicines’ in and (eds.), International Public Goods and Transfer of Technology under a Globalized Intellectual Property Regime (Cambridge University Press, 2005), 393–424.CrossRefGoogle Scholar
‘The Doha Declaration on the TRIPS Agreement and Public Health and the Contradictory Trend in Bilateral and Regional Free Trade Agreements’ (Quaker United Nations Office Occasional Paper No 14, 2004) www.quno.org at 28 January 2009.
‘The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a Dark Corner at the WTO’ (2002) 5 Journal of International Economic Law469.CrossRefGoogle Scholar
‘The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health’ (2005) 99 The American Journal of International Law317.CrossRefGoogle Scholar
‘Toward a New Era of Objective Assessment in the Field of TRIPS and Variable Geometry for the Preservation of Multilateralism’ (2005) 8 Journal of International Economic Law77.CrossRefGoogle Scholar
and , Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow's World (Cheltenham and Northampton, MA: Edward Elgar, 2009).CrossRefGoogle Scholar
and , ‘The Doha Round's Public Health Legacy: Strategies for the Protection and Diffusion of Patented Medicines under the Amended TRIPS Provisions’ (2007) 10(4) Journal of International Economic Law921.CrossRefGoogle Scholar
, www.aids-freeworld.org/.
, ‘Brazil Issues Compulsory License on Efavirenz’, Aidsmap (7 May 2007) www.aidsmap.com/news at 20 March 2009.Google Scholar
and , ‘Systems Biology: A Disruptive Biopharmaceutical Research Paradigm’ (2006) 74 Technological Forecasting and Social Change1643.CrossRefGoogle Scholar
, ‘India Cancer Patients Seek to Use Courts for Access to Patented Drugs’, Intellectual Property Watch, 3 April 2003, www.ip-watch.org/weblog/2008/04/03/india-cancer-patients-seek-to-use-courts-for-access-to-patented-drugs/ at 11 February 2009.Google Scholar
, ‘Rejected Novartis Cases Leave India's TRIPS Compliance Unchallenged’, (7 August 2007) Intellectual Property Watch, www.ip-watch.org/weblog/index.php?p=712 at 20 March 2009.Google Scholar
, The Truth about the Drug Companies: How They Deceive Us and What to Do about It (New York: Random House, 2004).Google Scholar
, ‘Discretion and Legitimacy in International Regulation’ (1993–4) 107 Harvard Law Review1099.Google Scholar
, and , ‘Multinational Firms, FDI Flows and Imperfect Capital Markets’ (Working Paper No W12855, National Bureau of Economic Research, 2007).
, ‘Weeds, Seeds and Deeds: Recent Skirmishes in the Seed Wars’ (2003) 11 Cardozo Journal of International and Comparative Law247.Google Scholar
, ‘TRIPS as Competitive and Cooperative Interpretation’ in and (eds.), Interpreting and Implementing the TRIPS Agreement (Cheltenham and Northampton, MA: Edward Elgar, 2008)Google Scholar
, ‘Generating Sustainable Funds through Branding: RED Campaign Introduces New Business Model for CSR’ (2007) 1(1) Journal of Business and Public Policy1.Google Scholar
, ‘WHO: Flesh-Eating Disease Making Comeback’, FoxNews.com (online), 25 January 2007.
, and , ‘Patenting and Licensing in Genetic Testing’ (2008) 16 European Journal of Human Genetics53.CrossRefGoogle ScholarPubMed
, ‘A Deconstruction of Novartis's Defense of its Challenge to the India Patent Regime’, Consumer Project on Technology, 7 February 2007, www.cptech.org/ip/health/c/india/hgap02072007.html at 27 March 2009.
‘Arthritic Flexibilities for Accessing Medicines: Analysis of WTO Action Regarding Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health’ (2004) 14 Indiana International and Comparative Law Review613.Google Scholar
‘GSK Access to Medicines: The Good, the Bad, and the Illusory’, Intellectual Property Health List, 15 February 2009.Google Scholar
, and , ‘Premiere Law Firm's Specious Arguments on Thailand's Compulsory Licenses’, IP Health, 25 April 2007.
and , ‘Promoting Good Ideas on Drugs: Are Patents the Best Way? The Relative Efficiency of Patent and Public Support for Bio-Medical Research’ (Briefing Paper, Center for Economic and Policy Research, 2002).
, ‘The Pharmaceutical Industry and Corporate Social Responsibility’, 2003, International Federation of Pharmaceutical Manufacturers Associations, www.responsiblepractice.com/english/insight/ifpma/ at 18 May 2009.Google Scholar
, ‘The Transactional Role of Patents: The Case of Product Development Partnerships’ (Paper presented at the Global Governance of HIV/AIDS: Intellectual Property and Access to Essential Medicines Conference, University of Liverpool, 8 October 2008).
, ‘Differential Pricing and Politics of Health Development’, 25 April 2001, Third World Network, www.twnside.org.sg/title/politics.htm at 6 February 2009.
, and , ‘Advance Market Commitments: A Policy to Stimulate Investment in Vaccines for Neglected Diseases’ (2006) Economists' Voice, www.bepress.com/ev at 10 February 2009.CrossRefGoogle Scholar
, Free Trade, Sovereignty, Democracy: The Future of the World Trade Organization (Washington, DC: American Enterprise Institute Press, 2001).Google Scholar
, ‘Isolation of a T-lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)’ (1983) 220 Science868–71.CrossRefGoogle Scholar
and , ‘Shallow Cuts: GSK's Voluntary Price Reductions and Patent Pooling Are Not Enough’ (4 March 2009) Policy Innovations, www.policyinnovations.org/ideas/commentary/data/000113.Google Scholar
and (eds.), Regional Trade Agreements and the WTO Legal System (Oxford University Press, 2006).CrossRef
, ‘New Trends in Technology Transfer’ (Issue Paper No 18, International Centre for Trade and Sustainable Development, 2007).
, ‘India's New Patent Regime: Aiding Access or Abetting Genericide’ (2007) 9(2) International Journal of Biotechnology122.CrossRefGoogle Scholar
, ‘The “Glivec” Patent Saga: A 3-D Perspective on Indian Patent Policy and Trips Compliance’ (2007) ATRIP, www.atrip.org/upload/files/essays/Shamnad%20Basheer%20Glivec%20Patent%20Saga.doc at 11 August 2008.
and , ‘The “Efficacy” of Indian Patent Law: Ironing Out the Creases in Section 3(d)’ (2008) 5 Script-ed232, www.law.ed.ac.uk/ahrc/script-ed/vol5–2/basheer.asp at 15 January 2009.CrossRefGoogle Scholar
, ‘India and the Drug Patent Wars’, Health Policy Outlook (7 February 2007), www.aei.org/outlook/25566.Google Scholar
and , ‘Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review’ (2003) 289 Journal of the American Medical Association545.Google ScholarPubMed
, The Wealth of Networks: How Social Production Transforms Markets and Freedom (New Haven, CT and London: Yale University Press, 2006).Google Scholar
and (eds.), Globalisation and Health: Challenges for Bioethics and Health Law (Dordrecht: Springer, 2006).CrossRef
and , ‘The Empire's New Clothes: Political Economy and the Fragmentation of International Law’ (2007) 60 Stanford Law Review595.Google Scholar
, , , , , and , ‘Advance Market Commitments for Vaccines against Neglected Diseases: Estimating Costs and Effectiveness’ (2007) 16 Health Economics491.CrossRefGoogle ScholarPubMed
., Praxis and Action (Philadelphia, PA: University of Pennsylvania Press, 1971, new edn, 1991).Google Scholar
and , Patent Failure: How Judges, Bureaucrats and Lawyers Put Innovators at Risk (Princeton University Press, 2008).Google Scholar
, ‘Are Developing Countries Going Too Far on TRIPS? A Closer Look at the New Laws in India’ (2008) 34 American Journal of Law and Medicine413.CrossRefGoogle Scholar
, Will to Live: AIDS Therapies and the Politics of Survival (Princeton University Press, 2007).Google Scholar
and , ‘The Case against Intellectual Property’ (2002) 92 American Economic Review209.CrossRefGoogle Scholar
, ‘Can South Africa Fight AIDS? Reconciling the South African Medicines and Related Substances Act with the TRIPS Agreement’ (2001) 19(2) Boston University International Law Journal273.Google Scholar
, ‘Message 2U: Editorial’, Vanity Fair, July 2007.
‘Product (RED)’, 12 October 2006; reprinted at action.one.org/blog/?p=195.
, ‘Foreword’, in (ed.), The Gaia Atlas of Future Worlds: Challenge and Opportunity in an Age of Change (New York: Anchor Books/Doubleday, 1990).Google Scholar
, ‘A Manifesto on WIPO and the Future of Intellectual Property’ (2004) 9 Duke Law and Technology Review1–12, www.law.duke.edu/journals/dltr/articles/pdf/2004DLTR0009.pdf.Google Scholar
The Public Domain: Enclosing the Commons of the Mind (New Haven, CT and London: Yale University Press, 2008).Google Scholar
, and , Intellectual Property Rights and Economic Development (Washington, DC: World Bank, 2000).CrossRefGoogle Scholar
, ‘The Uncensored Idea’, in (ed.), The Crossroads: Essays on Health Care in Modern America (Baltimore, MD: Johns Hopkins University, 2008).Google Scholar
(ed.), The Crossroads: Essays on Health Care in Modern America (Baltimore, MD: Johns Hopkins University, 2008).
, ‘The Impact of TRIPS: Intellectual Property Protection in Developing Countries’ (1994) 31 Common Market Law Review1245.Google Scholar
, International Governance in the WTO: Judicial Boundaries and Political Capitulation (London: Cameron, 2004).Google Scholar
and (eds.), The Shifting Allocation of Authority in International Law (Oxford and Portland, ME: Hart Publishing, 2008).
and , Adjusting Society: The World Bank, the IMF and Ghanaians (London: I. B. Tauris, 1996).Google Scholar
and , The Patent Crisis and How Courts Can Solve It, (University of Chicago Press, 2009).CrossRefGoogle Scholar
and , Monitoring Financial Flows for Health Research: Prioritizing Research for Health Equity (Geneva: Global Forum for Health Research, 2008).Google Scholar
, ‘Treating the Legal Side Effects of Cipro: A Reevaluation of Compensation Rules for Government Takings of Patent Rights’ (2002) 40 American Business Law Journal125.CrossRefGoogle Scholar
, Jr, ‘Defining Goals and Conditions for a Sustainable World’ (1997) 105 Environmental Health Perspectives1164.CrossRefGoogle ScholarPubMed
, ‘An Economic Analysis of Property Rights in Information: Justifications and Problems of Exclusive Rights, Incentives to Generate Information, and the Alternative of a Government-Run Reward System’ (1998) 9 Fordham Intellectual Property, Media & Entertainment Law Journal301.Google Scholar
and , ‘Patents and Public Health: Principle, Politics and Paradox’ (2005) 131 Proceedings of the British Academy331.Google Scholar
, ‘Is Prozac Better? Is It Even Different?’, The New York Times, 21 September 2004.
, Timely Demise for Free Trade Area of the Americas (23 November 2005) Americas Program, Center for International Policy, americas.irc-online.org/am/2954 at 2 February 2009.
, The Constitutionalization of the World Trade Organization: Legitimacy, Democracy, and Community in the International Trading System (Oxford University Press, 2005).CrossRefGoogle Scholar
, ‘Private Property, Collective Property, and Public Property in the Age of Genomics’ (2002) 54(171) International Social Sciences Journal83.Google Scholar
, ‘Patent Law for New Medical Uses of Known Compounds and Pfizer's Viagra Patent’ (2006) 46 IDEA283.Google Scholar
, , , , , , , , and , ‘Tropical Diseases Lacking Adequate Control Measures: Dengue, Leishmaniasis, and African Trypanosomiasis’, in , , , , , , , and (eds.), Disease Control Priorities in Developing Countries (2nd edn, Oxford University Press, 2006) 451.Google ScholarPubMed
, ‘Lobbying – Pharmaceuticals/Health Products: Industry Profile’, (2008) www.opensecrets.org/lobby/indusclient.php?lname=H04&year=2008 at 19 February 2009.
‘Pharmaceuticals/Health Products: Long-Term Contribution Trends’, www.opensecrets.org/industries/indus.php?ind=H04 at 19 February 2009.
and , ‘Patent Rights and Local Working under the WTO TRIPS Agreement: An Analysis of the U.S.–Brazil Patent Dispute’ (2002) 27(2) The Yale Journal of International Law365–93.Google Scholar
, ‘Is Product Patent Protection Necessary in Developing Countries for Innovation’ (Working Paper No 614, Indian Institute of Management, Calcutta, 2007).
, ‘The Role of the Judge in Public Law Litigation’ (1976) 89 Harvard Law Review1281.CrossRefGoogle Scholar
and , The New Sovereignty: Compliance with International Regulatory Agreements (Cambridge, MA: Harvard University Press, 1995).Google Scholar
, ‘Gateways to the Precautionary Principle in WTO Law’ (2007) 19 Journal of Environmental Law155.CrossRefGoogle Scholar
, and , ‘Data Sharing and Intellectual Property in Genomic Epidemiology Network: Policies for Large-Scale Research Collaboration’ (2006) 84 Bulletin of the World Health Organization382.CrossRefGoogle ScholarPubMed
, ‘Intellectual Property and the Development Divide’ (2006) 27 Cardozo Law Review2821.Google Scholar
, , and , Patent Pools: A Solution to the Problem of Access in Biotechnology Patents (Washington, DC: United States Patent and Trademark Office, 2000).Google Scholar
and , ‘New Data on African Health Professionals Abroad’ (2008) 6(1) Human Resources for Health, www.human-resources-health.com/content/6/1/1.CrossRefGoogle ScholarPubMed
, Contributor Information, www.clintonfoundation.org/contributors/index.html at 10 March 2009.
Treating HIV/AIDS & Malaria: Clinton HIV/AIDS Initiative – Our Approach, www.clintonfoundation.org/cf-pgm-hs-ai-home.htm at 10 March 2009.
‘William J. Clinton Foundation Publishes Names of All Contributors on Foundation Website’ (Press Release, 18 December 2008).
, Our Model, www.clintonglobalinitiative.org/ at 10 March 2008.
and , ‘Giving: A Conversation between President Clinton and Bill Gates’, The Clinton Global Initiative (2008 Annual Meeting Transcript) (24 September 2008), www.clintonglobalinitiative.org/ at 10 March 2009.
, ‘The Changing Structure of the Pharmaceutical Industry’ (2004) 23 Health Affairs10.CrossRefGoogle ScholarPubMed
and , ‘Public–Private Interaction and the Productivity of Pharmaceutical Research’ (Working Paper No 6018, National Bureau of Economic Research, 1997).
, ‘Gates Foundation Rearranges Public Health Universe’ (2002) 295 Science 2000.CrossRefGoogle ScholarPubMed
, and , ‘Protecting their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not)’ (Working Paper No 7552, National Bureau of Economic Research, 2000).CrossRef
, and , ‘Addressing Legal and Political Barriers to Global Pharmaceutical Access: Options for Remedying the Impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the Imposition of TRIPS-Plus Standards’ (2008) 3 Health Economics, Policy and Law229.CrossRefGoogle ScholarPubMed
, and , ‘Variations on a Theme: Cataloguing Human DNA Sequence Variation’ (1997) 278 Science1580.CrossRefGoogle Scholar
, ‘The Political Economy of the Pharmaceutical Industry’ (1986) 24 Journal of Economic Literature1178.Google ScholarPubMed
, ‘Statement of Information to the Competition Commission of South Africa on Complaint against GlaxoSmithKline and Boehringer Ingelheim’ (3 February 2003) www.cptech.org/ip/healthcl/cl-cases/rsa-tac/cptech-statement.doc.
, ‘The Bangkok Challenge: From Conflict to Cooperation and Beyond – Outcomes Report’ (2007) The Lowy Institute for International Policy, 2–5, www.lowyinstitute.org/Publication.asp?pid=612 at 20 March 2009.Google Scholar
, ‘Regulatory Data Protection in Pharmaceuticals and Other Sectors’, in , , , , , , , and (eds.), Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (Oxford: Centre for the Management of Intellectual Property in Health Research and Development, 2008), 437.Google Scholar
, ‘The Science Commons in Health Research: Structure, Function, and Value’ (2007) 32 Journal of Technology Transfer133.CrossRefGoogle Scholar
, The Cultural Life of Intellectual Properties: Authorship, Appropriation, and the Law (Durham, NC and London: Duke University Press, 1998).CrossRefGoogle Scholar
, The Welfare of Citizens: Developing New Social Rights (London: Institute of Public Policy Research, 1992).Google Scholar
, ‘Implications of Bilateral Free Trade Agreements on Access to Medicines’ (2006) 84 Bulletin of the World Health Organization399.CrossRefGoogle ScholarPubMed
, Intellectual Property Rights, the WTO and Developing Countries: The TRIPS Agreement and Policy Options (New York: Zed Books, Third World Network, 2000).Google Scholar
, Trade Related Aspects of Intellectual Property Rights: A Commentary on the TRIPS Agreement (Oxford University Press, 2007).CrossRefGoogle Scholar
, ‘TRIPS and TRIPS Plus Protection in Latin America’ in (ed.), Intellectual Property, Trade and Development (Oxford University Press, 2007), 221.Google Scholar
and , ‘The WIPO Patent Agenda: The Risks for Developing Countries’ (Working Paper No 12, Trade-Related Agenda, Development and Equity, South Centre, 2002).
, ‘Use of Indicators to Compare Supply Chains in the Coffee Industry’ (2004) 43 Greener Management International93.Google Scholar
, ‘EU Decries Thailand for Using Licensing to Get Medicine’, Interpress Service, 2 March 2008.
, ‘EU Split over Thai Effort to Obtain Cheaper Patented Drugs’, Intellectual Property Watch, 5 September 2007, www.ip-watch.org/weblog/index.php?p=732&res=1024_ff&print=0 at 15 April 2009.
, ‘European Parliament Set to Reprimand Mandelson for Pressuring Thailand’, IP Watch, 9 May 2008, www.ip-watch.org/weblog/index.php?p=1032 at 20 March 2009.
, ‘The Error of Positive Rights’ (2001) 48 University of California Los Angeles Law Review857.Google Scholar
, , , and , Global Forum Health 10/90 Report 2003–2004 (Geneva: Global Forum for Health Research, 2004).Google Scholar
, Just Health: Meeting Health Needs Fairly (Cambridge University Press, 2007).CrossRefGoogle Scholar
and , ‘Theory and Implementation of Differential Pricing for Pharmaceuticals’, in and (eds.), International Public Goods and Transfer of Technology under a Globalized Intellectual Property Regime (Cambridge University Press, 2005), 425–56.CrossRefGoogle Scholar
(ed.), Implementing the World Intellectual Property Organization's Development Agenda (Ottawa: Wilfred Laurier University Press, 2009).
, The TRIPS Regime of Patent Rights (Alphen aan den Rijn: Kluwer Law International, 2003).Google Scholar
and , Monitoring Financial Flows for Health Research 2006: The Changing Landscape of Health Research for Development (Geneva: Global Forum for Health Research, 2006).Google Scholar
, ‘The Case for Open-Source Software in Drug Discovery’ (2005) 10 Drug Discovery Today213.CrossRefGoogle ScholarPubMed
and , ‘Neither Market nor Hierarchy nor Network: The Emergence of Bazaar Governance’ (2006) 27 Organization Studies1447.CrossRefGoogle Scholar
and , ‘Justiciability of Economic, Social, and Cultural Rights: Should There Be an International Complaints Mechanism to Adjudicate the Rights to Food, Water, Housing, and Health?’ (2004) 98 American Journal of International Law462.CrossRefGoogle Scholar
, and , Survey of Pharmacoeconomic Assessment Activity in Eleven Countries (Health Working Paper No 4, OECD, 2003).CrossRefGoogle Scholar
, and , ‘The Price of Innovation: New Estimates of Drug Development Costs’ (2003) 22 Journal of Health Economics151.CrossRefGoogle Scholar
, , and , ‘The Cost of Innovation in the Pharmaceutical Industry’ (1991) 10 Journal of Health Economics107.CrossRefGoogle ScholarPubMed
and , ‘The Economics of Follow-On Drug Research and Innovation: Trends in Entry Rates and the Timing of Development’ (2004) 22 Pharmacoeconomics1.CrossRefGoogle Scholar
, ‘The International Intellectual Property Law System: New Actors, New Institutions, New Sources’ (2004) 8 Proceedings of the 98th Annual Meeting of the American Society of International Law213.Google Scholar
and , ‘Diversifying without Discriminating: Complying with the Mandates of the TRIPS Agreement’ (2007) 13 Michigan Telecommunication and Technology Law Review445.Google Scholar
and , ‘Intellectual Property Law and the Public Domain of Science’ (2004) 7 Journal of International Economic Law431.CrossRefGoogle Scholar
and , ‘TRIPS and the Dynamics of International Property Lawmaking’ (2004) 36 Case Western Reserve Journal of International Law95.Google Scholar
and (eds.) Trademark Law and Theory: A Handbook of Contemporary Research (Cheltenham and Northampton, MA: Edward Elgar, 2008).CrossRef
, ‘Hilary Shocked at Obama's Choice’, The Sydney Morning Herald, 4 December 2008.
, ‘An Alternative Framework for the Global Regulation of Intellectual Property Rights’ (2005) 21(4) Journal Für Entwicklungspolitik44.CrossRefGoogle Scholar
, ‘BITS and BIPS: Bilateralism in Intellectual Property’ (2001) 4 Journal of World Intellectual Property791–808.CrossRefGoogle Scholar
, ‘Expanding Intellectual Property's Empire: The Role of FTAs’ (2003) International Centre for Trade and Sustainable Development, ictsd.net/i/ip/24737/ at 2 March 2009.Google Scholar
, ‘Global Property Rights in Information: The Story of TRIPS at the GATT’ (1995) 13 Prometheus1.CrossRefGoogle Scholar
, ‘Negotiating Intellectual Property Rights: Between Coercion and Dialogue’, in and (eds.), Global Intellectual Property Rights: Knowledge, Access and Development (New York: Palgrave Macmillan, 2002), 161.CrossRefGoogle Scholar
, ‘The Regulation of Public Goods’ (2004) 7 Journal of International Economic Law321.CrossRefGoogle Scholar
, ‘Weaving Webs of Influence: The United States, Free Trade Agreements and Dispute Resolution’ (2007) 41(1) Journal of World Trade191–210.Google Scholar
and , Information Feudalism: Who Owns the Knowledge Economy? (London: Earthscan, 2002).Google Scholar
and (eds.), Global Intellectual Property Rights: Knowledge, Access and Development (New York: Palgrave Macmillan, 2002).CrossRef
‘Expressive Genericity: Trademarks as Language in the Pepsi Generation’ (1989–90) 65 Notre Dame Law Review397.Google Scholar
‘Reconciling Trademark Rights and Expressive Values: How to Stop Worrying and Learn to Love Ambiguity’, in and (eds.) Trademark Law and Theory: A Handbook of Contemporary Research (Cheltenham, UK and Northampton, MA: Edward Elgar, 2008), 261.Google Scholar
‘Regulating Dynamic Innovation in a Complex Political Economy: Administering Intellectual Property on the International Stage’ (Paper presented at the CPR and NYU Workshop on Global Regulatory Governance: India, the South and the Shaping of Global Administrative Law, The Ambassador Hotel, New Delhi, 5–6 January 2008).
‘TRIPS – Round II: Should Users Strike Back?’ (2004) 71 University of Chicago Law Review21.Google Scholar
and , ‘Two Achievements of the Uruguay Round: Putting TRIPS and Dispute Settlement Together’ (1997) 37 Virginia Journal of International Law275.Google Scholar
, and (eds.), Expanding the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society (Oxford University Press, 2001).
, Fatal Imbalance: The Crisis in Research and Development for Drugs for Neglected Diseases (Geneva: Médecins Sans Frontières and Drugs for Neglected Diseases Working Group, 2001) (also at www.msf.org/source/access/2001/fatal/fatal.pdf).Google Scholar
, ‘Duke Faculty Propose Incentives for Developing Drugs for Neglected Diseases’, Duke University, 7 March 2006.
, ‘Who Decides the Extent of Rights in Intellectual Property?’, in , and (eds.), Expanding the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society (Oxford University Press 2001), 405.Google Scholar
, and , ‘Patent Pools and Standard Setting in Diagnostic Genetics’ (2005) 23 Nature Biotechnology937.CrossRefGoogle ScholarPubMed
, ‘India's Choice’, The New York Times, 18 January 2005.
, ‘Open-Source Science to Enable Drug Discovery’ (2008) 13 Drug Discovery Today731.CrossRefGoogle ScholarPubMed
, ‘Competing Models of EU Legitimacy: The Test of Popular Expectations’ (2008) 46 Journal of Common Market Studies619.CrossRefGoogle Scholar
and , ‘Decision-Making in the World Trade Organization’ (2005) 8 Journal of International Economic Law51.CrossRefGoogle Scholar
and , ‘The Authoritative Interpretation under Article IX:2 of the Agreement Establishing the World Trade Organization: Current Law, Practice and Possible Improvements’ (2005) 8 Journal of International Economic Law803.CrossRefGoogle Scholar
, ‘Patents and the Progress of Science: Exclusive Rights and Experimental Use’ (1989) 56 University of Chicago Law Review1017.CrossRefGoogle Scholar
and , ‘Public vs. Proprietary Science: A Fruitful Tension?’ (2002) 77 Academic Medicine1392.CrossRefGoogle ScholarPubMed
, ‘Delivery Past Due: Global Precedent Set under Canada's Access to Medicines Regime’ (2008) 13(1) Canadian HIV/AIDS Policy and Law Review1.Google ScholarPubMed
, ‘Steps Forward, Backward, and Sideways: Canada's Bill on Exporting Generic Pharmaceuticals’ (2004) 9(3) Canadian HIV/AIDS Policy and Law Review1.Google ScholarPubMed
, ‘TRIPS from Doha to Cancún … to Ottawa: Global Developments in Access to Treatment and Canada's Bill C-56’ (2003) 8(3) Canadian HIV/AIDS Policy and Law Review1.Google Scholar
, ‘Free Trade Agreements as Surrogates for TRIPs-Plus’ (2006) 28 European Intellectual Property Review374.Google Scholar
, The Invisible Cure: Africa, the West, and the Fight against AIDS (New York: Farrar, Straus and Giroux, 2007).Google Scholar
., Essential Medical Inventions Licensing Agency Working Plan – June 2008 (rev. 17 July 2008), www.keionline.org/index.php?option=com_content&task=view&id=63&Itemid=1 at 2 March 2009.
, Essential Patent Pool for AIDS (EPPA): Background Information (2005), www.essentialinventions.org/docs/eppa/ at 26 February 2009.
, ‘Good Governance at the Supranational Scale: Globalizing Administrative Law’ (2006) 115 Yale Law Journal1490.CrossRefGoogle Scholar
, Interim ECDC Scientific and Public Health Briefing: Sharing Influenza Virus Samples (2008), ecdc.europa.eu/pdf/ECDC_influenza_briefing.pdf at 9 March 2009.
, ‘Strategic Patent Licensing for Public Research Organizations: Deploying Restriction and Reservation Clauses to Promote Medical R&D in Developing Countries’ (2008) 34(2–3) American Journal of Law and Medicine175–223.Google ScholarPubMed
, ‘Patent Wars in the Valley of the Shadow of Death: The Pharmaceutical Industry, Ethics and Global Trade’ (2005) 59 University of Miami Law Review203.Google Scholar
, Pathologies of Power: Health, Human Rights, and the New War on the Poor (Berkeley, CA and London: University of California Press, 2005).Google Scholar
, ‘Global Intellectual Property Protection for Innovative Pharmaceuticals: Challenges for Bioethics and Health Law’, in and (eds.), Globalisation and Health: Challenges for Bioethics and Health Law (Dordrecht: Springer, 2006), 87.CrossRefGoogle Scholar
, ‘Reference Pricing for Pharmaceuticals: Is the Australia–United States Free Trade Agreement Affecting Australia's Pharmaceutical Benefits Scheme?’ (2007) 187 Medical Journal of Australia240.Google ScholarPubMed
, ‘Toward a Treaty on Safety and Cost-Effectiveness of Pharmaceuticals and Medical Devices: Enhancing an Endangered Global Public Good’ (2006) 2 Globalization and Health5.CrossRefGoogle Scholar
, Who Owns our Health?: Medical Professionalism, Law and Leadership beyond the Age of the Market State (Sydney: University of New South Wales Press, 2007).Google Scholar
, , , , , and , ‘Assessing the Impact of the Australia–United States Free Trade Agreement on Australian and Global Medicines Policy’ (2005) 1(15) Globalisation and Health1.Google ScholarPubMed
and , ‘Linkage Pharmaceutical Evergreening in Canada and Australia’ (2007) 4 Australian and New Zealand Journal of Health Policy8.CrossRefGoogle ScholarPubMed
and , ‘Three Proposals for Rewarding Novel Health Technologies Benefitting People Living in Poverty: A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty’ (2008) 1(2) Public Health Ethics146.CrossRefGoogle Scholar
, ‘The Global Fund Welcomes RED’ (Press Release, 26 January 2006), www.joinred.com/news/press-release.asp?145141242006 at 10 March 2009.
, ‘The Political Economy of United States’ Free Trade Arrangements' (2003) 26 World Economy1019.CrossRefGoogle Scholar
, , and (eds.), Perspectives on Free and Open Source Software (Cambridge, MA: MIT Press, 2005).
, ‘Fighting the Axis of Illness: HIV/AIDS, Human Rights and US Foreign Policy’ (2004) 17 Harvard Human Rights Journal99.Google Scholar
and (eds.), Poor People's Knowledge: Promoting Intellectual Property in Developing Countries (Washington, DC: The World Bank, 2004), 75.
, Intellectual Property and Public Health: An Overview of the Debate with a Focus on US Policy (Washington, DC: Center for Global Development, 2008).Google Scholar
‘Intellectual Property Rights and US and German International Transactions in Manufacturing Industries’ (Manuscript, The World Bank, 1997).
and (eds.), Intellectual Property and Development: Lessons from Recent Economic Research (Washington, DC: The World Bank, 2005).
and , ‘Tightening TRIPS: The Intellectual Property Provisions of Recent US Free Trade Agreements’ (2005) 20 The World Bank Trade Note, siteresources.worldbank.org/INTRANETTRADE/Resources/Pubs/TradeNote20.pdf at 23 January 2009.Google Scholar
and (, trans.), ‘Regime-Collisions: The Vain Search for Legal Unity in the Fragmentation of Global Law’ (2004) 25 Michigan Journal of International Law999.Google Scholar
., Promises to Keep: Technology, Law, and the Future of Entertainment (Stanford University Press, 2004).Google Scholar
. and , Drugs, Law, and the Health Crisis in the Developing World (Stanford: Stanford University Press, 2010, forthcoming).Google Scholar
. and , ‘Global Justice in Health Care: Developing Drugs for the Developing World’ (2007) 40 University of California Davis Law Review581.Google Scholar
, The Foundation: A Great American Secret; How Private Money Is Changing the World (New York: Public Affairs, 2007).Google Scholar
, and , ‘An Economic Justification for Open Access to Essential Medicine Patents in Developing Countries’ (2009) 37 Journal of Law, Medicine & Ethics184.CrossRefGoogle ScholarPubMed
, and , ‘Postmarketing Surveillance: Lack of Vigilance, Lack of Trust’ (2002) 292 Journal of the American Medical Association2647.CrossRefGoogle Scholar
, ‘The “Transformative Constitution”: Treatment Action Campaign and the Politics of Social Rights in South Africa’ (Working Paper, 8 October 2008), ssrn.com/abstract=1292879 at 2 March 2009.
, ‘Incentivizing Justice: Linking Human Rights, Trade and Access to Medicines’ (MCIS Briefings, Comparative Program on Health and Society Lupina Foundation Working Papers Series, 2005–6).
, ‘Trade Rules, Intellectual Property, and the Right to Health’ (2007) 21 Ethics and International Affairs337.CrossRefGoogle Scholar
. and , ‘On the Margins of the Human Rights Discourse’, in and Jr (eds.), Economic Rights in Canada and the United States (Philadelphia, PA: University of Pennsylvania Press, 2006), 55, 69.Google Scholar
, ‘Can the United States Delegate Aspects of Sovereignty to International Regimes?’, in (ed.), Delegating State Powers: The Effect of Treaty Regimes on Democracy and Sovereignty (New York: Transnational Publishers, 2000).Google Scholar
, (ed.), Delegating State Powers: The Effect of Treaty Regimes on Democracy and Sovereignty (New York: Transnational Publishers, 2000).
, ‘A Patentable Invention: Will Current Proposed Law Reform Clarify Patentable Subject Matter?’ (2005) New Zealand Business Law Quarterly350.Google Scholar
, ‘Costly RED Campaign Reaps Meager $18 Million: Bono & Co. Spend Up to $100 Million on Marketing, Incur Watchdogs’ Wrath', Advertising Age (New York), 5 March 2007.Google Scholar
and (eds.) Appealing to the Future: Michael Kirby and his Legacy (Sydney: Law Book Co., 2009).
& , The Asian Generic Pharmaceutical Market (2002), pharmalicensing.com at 5 February 2009.
& , The Generic Invasion – An Inside Scoop to the Pot of Gold (2003), pharmalicensing.com at 5 February 2009.
, ‘Patent Policy and Costly Imitation’ (1992) 23 Randal Journal of Economics52.CrossRefGoogle Scholar
and , ‘Intellectual Property: When Is It the Best Incentive System?’ (Working Paper No E01–303, University of California, Berkeley, Department of Economics, 2001).
, ‘Statement’, New Scientist, 7 October 2008, www.newscientist.com/commenting/thread?id=dn14881–4.
, , et al., ‘Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS’ (1984) 224 Science500–3.CrossRefGoogle Scholar
, and (eds.), Courts and Social Transformation in New Democracies: An Institutional Voice for the Poor (Aldershot and Burlington, CA: Ashgate, 2006).
and , ‘Sharing H5N1 Viruses to Stop a Global Influenza Pandemic’ (2007) 4(11) Public Library of Science Medicine1712, doi:10.1371/journal.pmed.0040330 at 9 March 2009.Google ScholarPubMed
, ‘Making Capitalism More Creative’, Time Magazine, 31 July 2008.
, ‘Remarks at the World Health Assembly’ (Speech delivered at the 58th World Health Assembly, Geneva, Switzerland, 16 May 2005), www.who.int/mediacentre/events/2005/wha58/gates/en/index.html at 10 March 2009.
, ‘The Legal Status of the Doha Declaration on TRIPS and Public Health under the Vienna Convention on the Law of Treaties’ (2002) 15 Harvard Journal of Law and Technology291.Google Scholar
and (eds.), Courting Social Justice: Judicial Enforcement of Social and Economic Rights in the Developing World (Cambridge University Press, 2008).CrossRef
, and , ‘Towards a Balanced Interpretation of the “Three-Step Test” in Copyright Law’ (2008) 30(12) European Intellectual Property Review489.Google Scholar
, ‘Brazil Takes Steps to Import Cheaper AIDS Drug under Trade Law’, Intellectual Property Watch (7 May 2007), www.ip-watch.org/weblog/index.php?p=614 at 20 March 2009.
(ed.), Intellectual Property, Trade and Development: Strategies to Optimize Economic Development in a TRIPS-Plus Era (Oxford University Press, 2007).
The TRIPS Agreement: Drafting History and Analysis (2nd edn, London: Sweet & Maxwell, 2003).Google Scholar
, ‘Antitrust for Patent Pools: A Century of Policy Evolution’ (2004) Stanford Technology Law Review3.Google Scholar
, ‘Common Property, Private Property and Equity: Clash of Values and the Quest to Preserve Biodiversity’ (1995) 12 Environmental and Planning Law Journal388.Google Scholar
, ‘The Lessons of User Fee Experience in Africa’ (1997) 12 Health Policy and Planning273.CrossRefGoogle ScholarPubMed
, ‘Corporate Responsibility News’, www.globalethicsmonitor.com at 9 February 2009.
, The 10/90 Report on Health Research 2003–2004 (Geneva: Global Forum for Health Research, 2004), www.globalforumhealth.org at 16 February 2009.
, Pledges and Donations, www.theglobalfund.org/en/funds_raised/pledges/ at 10 March 2009.
, ‘Bill Gates on Pharmaceuticals: The System Isn't Working’, Wired Science (22 April 2008), blog.wired.com/wiredscience/2008/04/bill-gates-what.html at 10 March 2009.
, , , , and , Preliminary Legal Review of Proposed Medicines Patent Pool (Montreal: The Innovation Partnership, 2007).Google Scholar
, The AIDS Pandemic: Complacency, Injustice, and Unfulfilled Expectations (Chapel Hill, NC: The University of North Carolina Press, 2006).Google Scholar
, and , Priority Review Vouchers to Encourage Innovation for Neglected Diseases (Harvard Law School, 2008), www.law.harvard.edu/programs/petrie-flom/workshops_conferences/2008_workshops/Grabowski.pdf.
and , The Regulation of Pharmaceuticals: Balancing the Benefits and Risks (Washington, DC: American Enterprise Institute, 1983).Google Scholar
, Invalidity and the Law of Treaties (London: British Institute of International and Comparative Law, 2006).Google Scholar
, , , and (eds.), The Earth Summit Agreements: A Guide and Assessment (Washington DC: Brookings Institution Press, 1993).
and , ‘Toward Allocative Efficiency in the Prescription Drug Industry’ (1995) 73 Milbank Quarterly213.CrossRefGoogle ScholarPubMed
, WIPO's New Director General Outlines Challenges and Priorities (Geneva: World Intellectual Property Organization, 22 September 2008), www.wipo.int/about-wipo/en/dgo/dg_gurry_acceptance_speech_2008.html.Google Scholar
, ‘And if You Liked the Movie, a Netflix Contest May Reward You Handsomely’, The New York Times, 2 October 2006.
, ‘The World Intellectual Property Organization: Past, Present and Future’ (2007) 54 Journal of the Copyright Society of the USA253.Google Scholar
and (eds.), Capitalism, Culture, and Economic Regulation (Oxford: Clarendon Press, 1989).
and , ‘Organizing Regulatory Space’, in and (eds.), Capitalism, Culture, and Economic Regulation (Oxford: Clarendon Press, 1989), 271.Google Scholar
, ‘Cash for Answers’, Financial Times Magazine, 26 January 2008.
, ‘Les biens publics mondiaux et le droit international: quelques réflexions à propos de la gestion de l'intérêt commun’ (2002) 13 L'Observateur des Nations Unies137.Google Scholar
and , ‘Global Health Governance: Conflicts on Global Social Rights’ (2008) 8 Global Health Policy80.Google Scholar
, ‘Regime Shifting: The TRIPS Agreement and New Dynamics of International Intellectual Property Lawmaking’ (2004) 29 Yale Journal of International Law1.Google Scholar
, ‘Toward a Human Rights Framework for Intellectual Property’ (2007) 40 University of California Davis Law Review971.Google Scholar
, The Gridlock Economy: How Too Much Ownership Wrecks Markets, Stops Innovation and Costs Lives (New York: Basic Books, 2008).Google Scholar
and , ‘Can Patents Deter Innovation? The Anticommons in Biomedical Research’ (1998) 280 Science698.CrossRefGoogle ScholarPubMed
, Great Feuds in Medicine: Ten of the Liveliest Disputes Ever (New York: John Wiley & Sons, 2001).Google Scholar
, Constitutionalism, Democracy and Foreign Affairs (New York: Columbia University Press, 1990).Google Scholar
, Human Rights and the WTO: The Case of Patents and Access to Medicines (Oxford University Press, 2007).Google Scholar
, ‘Debunking “Conglomo-Talk”: A Case Study of the Amicus Curiae as an Instrument for Advocacy, Investigation and Mobilisation’ (2001) 5 Law, Democracy and Development133.Google Scholar
, ‘Federal Inquiry Finds Misconduct by a Discoverer of the AIDS Virus’, The New York Times, 31 December 1992.
, ‘Key Patent on AIDS to Favor the French’, The New York Times, 12 July 1994.
, and , ‘Transfer of Technology to Developing Countries: Unilateral and Multilateral Policy Options’ (2005) 33 World Development 1587.CrossRefGoogle Scholar
, ‘Essential Medicines and Human Rights: What Can They Learn from Each Other?’ (2006) 84 Bulletin of the World Health Organization371.CrossRefGoogle ScholarPubMed
, ‘An Efficient Reward System for Pharmaceutical Innovation’ (Working Paper, University of Calgary, 2005).
, ‘An Optimal Reward System for Neglected Disease Drugs’ (Unpublished, Department of Economics, University of Calgary, 2005).
, ‘Incentive Mechanisms for Innovation’ (Technical Paper No TP-07005, Institute for Advance Policy Research, University of Calgary, June 2007).
, Prize, Advanced Market Commitments and Pharmaceuticals for Developing Countries (2007), www.iprsonline.org/ictsd/Dialogues/2007-10-22/7%20ThinkPiece_Hollis.pdf at 10 February 2009.
, ‘The Health Impact Fund: A Useful Supplement to the Patent System?’ (2008) 1 Public Health Ethics124–33.CrossRefGoogle Scholar
and , The Health Impact Fund: Making New Medicines Accessible for All (New Haven, CT: Incentives for Global Health, 2008), www.yale.edu/macmillan/igh/hif_book.pdf.Google Scholar
, BioBazaar: Biotechnology and the Open Source Revolution (Cambridge, MA: Harvard University Press 2008).CrossRefGoogle Scholar
, ‘Alternative Approaches to IP Management: One-Stop Technology Platform Licensing’ (2003) 9 Journal of Commercial Biotechnology119.CrossRefGoogle Scholar
and Jr (ed.) Economic Rights in Canada and the United States (Philadelphia, PA: University of Pennsylvania Press, 2006).CrossRef
, , and , ‘The Innovation Gap in Pharmaceutical Drug Discovery and New Models for R&D Success’ (2007), www.kellogg.northwestern.edu/academic/biotech/faculty/articles/NewRDModel.pdf.
and , Conceiving an International Instrument on Limitations and Exceptions to Copyright: Final Report (Open Society Institute, 2008), www.ivir.nl/publications/hugenholtz/limitations_exceptions_copyright.pdf at 16 January 2009.
, ‘Charting the Path to the World Bank's “No Blanket Policy on User Fees”’ (DFID Health Systems Resource Centre, 2004), 2.5.
, ‘Initial Survey of the Contribution of the Copyright Industries to Economic Development’ (April 2005), www.iipa.com/pdf/2005_Apr27_Economic_Development_Survey.pdf at 23 April 2009.
, Patent Protection and Access to HIV/AIDS Pharmaceuticals in Sub-Saharan Africa (2000), www.iipi.org/reports/HIV_AIDS_Report.pdf at 5 February 2009.
, ‘Creating the Community Patent and its Court’, in and (eds.), Intellectual Property Law in the New Millennium: Essays in Honour of William R. Cornish (Cambridge University Press, 2004).Google Scholar
and , Innovation and its Discontents: How our Broken Patent System Is Endangering Innovation and Progress, and What to Do about It (Princeton University Press, 2004).Google Scholar
, and (eds.), Innovation Policy and the Economy, Vol. 1 (Cambridge, MA: MIT Press, 2001).
, , et al. (eds.), Disease Control Priorities in Developing Countries (2nd edn, Oxford University Press, 2006).PubMed
, ‘Does Foreign Direct Investment Increase the Productivity of Domestic Firms? In Search of Spillovers through Backward Linkages’ (2004) 94 American Economic Review605.CrossRefGoogle Scholar
, ‘Gates Philanthropy in Stem Cell Transplant for Damaged Heart’, The Institute of Science in Society, Press Release, 1 August 2007, www.i-sis.org.uk/GatesPhilanthropyStemCells.php at 10 March 2009.
, ‘Trade Agreements and Public Health: Are US Trade Negotiators Building an Intellectual Property Platform against the Generic Industry? Are They Raising the Standards to Go beyond the US Law?’ (2007) 4 Journal of Generic Medicines169.CrossRefGoogle Scholar
, ‘The Future of the Medical Bill’, The Times of India (Mumbai), 5 April 2007, www.cpaaindia.org/aboutus/PublicEyeAwards.htm at 6 September 2007.Google Scholar
, The Robber Barons: The Great American Capitalists, 1861–1901 (New York: Harcourt, Brace and Company, 1934).Google Scholar
, ‘Abbott to Stop Launching New Drugs in Thailand in Response to Country's Compulsory License for Antiretroviral Kaletra’, Kaiser News Network, 16 March 2007, www.medicalnewstoday.com/articles/65274.php at 20 March 2009.Google Scholar
and , ‘Does Intellectual Property Protection Spur Technological Change?’ (2001) Center Discussion Paper No 83, Economic Growth Center, Yale University.
, ‘The Access to Knowledge Mobilization and the New Politics of Intellectual Property’ (2008) 117 Yale Law Journal804.CrossRefGoogle Scholar
, , and , ‘Addressing Global Health Inequities: An Open Licensing Approach for University Innovations’ (2005) 20 Berkeley Technology Law Journal1031.Google Scholar
, Fostering R&D and Promoting Access to Medicines: Locating Common Ground: Operationalising Patent Pools for ARVs (International Centre for Trade and Sustainable Development, 2007).
, ‘The Revival of Confidence in the Patent System’ (1991) 73 Journal of Patent and Trademark Office Society5.Google Scholar
, and (eds.), Global Public Goods: International Cooperation in the 21st Century (New York: Oxford University Press, 1999).CrossRef
, Narrowing the Gap between Provision and Need for Medicines in Developing Countries (London: Office of Health Economics, 2000).Google Scholar
, ‘Patents, Compulsory License and Access to Medicines: Some Recent Experiences’, Policy Innovations, February 2007, www.policyinnovations.org/ideas/policy_library/data/patents_compulsory_license.Google Scholar
, ‘Patents System Facing Legitimacy Crisis’, Third World Network, 26 March 2001, www.twnside.org.sg/title/et0110.htm at 5 February 2009.Google Scholar
, ‘Coordination, Property, and Intellectual Property: An Unconventional Approach to Anticompetitive Effects and Downstream Access’ (2006) 56 Emory Law Journal327.Google Scholar
, and , ‘The Emergence of Global Administrative Law’ (2005) 68 Law and Contemporary Problems15.Google Scholar
and , ‘Provisions for Health and Health Care in the Constitutions of the Countries of the World’ (2004) 37 Cornell International Law Journal285.Google Scholar
, ‘Bill Gates and Warren Buffett Discuss “Creative Capitalism”’, Creative Capitalism (Interview Transcript, 2008), creativecapitalism.typepad.com/creative_capitalism/2008/06/bill-gates-and.html#more at 10 March 2009.Google Scholar
, (ed.), Creative Capitalism: A Conversation with Bill Gates, Warren Buffett and Other Economic Leaders (New York: Simon & Schuster, 2008).
, and , ‘Detention of Insolvent Patients in Burundian Hospitals’ (2008) Health Policy and Planning14.
, ‘Foreword’, in (ed.), Intellectual Property and Biotechnology: Biological Inventions (Cheltenham and Northampton, MA: Edward Elgar, 2008).Google Scholar
, ‘Competing Demands on Public Policy’ (Paper presented at the WIPO Conference on the International Patent System, Geneva, 25–27 March 2002).
, ‘The Patent System: A Design for All Seasons?’ (Paper presented at the WIPO Conference on the International Patent System, Geneva, 25–27 March 2002)
, ‘Cross Licensing and Antitrust Law’ (Speech delivered at the San Antonio Marriott Rivercenter, Texas, 2 May 1997).
, ‘Access to Essential Medicines – Promoting Human Rights over Free Trade and Intellectual Property Claims’, in and (eds.), International Public Goods and Transfer of Technology under a Globalized Intellectual Property Regime (Cambridge University Press, 2005), 481–92.CrossRefGoogle Scholar
, ‘Campaigning for Life: Building a New Transnational Solidarity in the Face of HIV/AIDS and TRIPS’, in and (eds.), Law and Globalization from Below: Towards a Cosmopolitan Legality (Cambridge University Press, 2005).Google Scholar
‘Law, Politics, and Access to Essential Medicines in Developing Countries’ (2008) 36 Politics and Society207.CrossRefGoogle Scholar
, ‘Cost Benefit Analysis of UNITAID Patent Pool’ (20 June 2008), http://www.keionline.org/misc-docs/1/cost_benefit_UNITAID_patent_pool.pdf at 10 March 2009.
, ‘KEI Statement to Resumed IGWG II Bis’, 1 May 2008.
, ‘Prizes to Stimulate Innovation’, www.keionline.org.
, ‘Selected Innovation Prizes and Reward Programs’ (Research Note 1, Knowledge Ecology International, 7 March 2008), www.keionline.org/misc-docs/research_notes/kei_rn_2008_1.pdf at 10 March 2009.
, ‘Statement of James Love, Director of Knowledge Ecology International on End of IGWG II Bis’ 3 May 2008, www.keionline.org/index.php?option=com_content&task=view&id=177&Itemid=1.
, ‘Brazil's IP Opportunism Threatens U.S. Private Property Rights’ (2007) 38 University of Miami Inter-American Law Review1.Google Scholar
, ‘Co-Payments Go Way Up for Drugs with High Prices’, The New York Times, 14 April 2008.
, ‘The Use of Non-Assertion Covenants: A Tool to Facilitate Humanitarian Licensing, Manage Liability and Foster Global Access’, in , , , , , , , and (eds.), Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (Oxford: Centre for the Management of Intellectual Property in Health Research and Development, 2008), 1739.Google Scholar
, , , , , , , and (eds.), Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (Oxford: Centre for the Management of Intellectual Property in Health Research and Development, 2008).
and , ‘Facilitating Assembly of and Access to Intellectual Property: Focus on Patent Pools and a Review of Other Mechanisms’, in , , , , , , , and (eds.), Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (Oxford: Centre for the Management of Intellectual Property in Health Research and Development, 2008), 131.Google Scholar
, , and , ‘Intellectual Property Management Strategies to Accelerate the Development and Access of Vaccines and Diagnostics: Case Studies on Pandemic Influenza, Malaria and SARS’ (2006) 2 Innovation Strategy Today67.Google Scholar
and , ‘Golden Rice: A Product-Development Partnership in Agricultural Biotechnology and Humanitarian Licensing’, in , , , , , , , and (eds.), Executive Guide to Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (Oxford: Centre for the Management of Intellectual Property in Health Research and Development, 2008), CS11.Google Scholar
, ‘Creating Markets for New Vaccines, Part I: Rationale’ (Working Paper No 7716, National Bureau of Economic Research, 2000).
, ‘Patent Buyouts: A Mechanism for Encouraging Innovation’ (1998) 113 Quarterly Journal of Economics 1137.CrossRefGoogle Scholar
and , Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases (Princeton University Press, 2004).Google Scholar
, and , The Intellectual and Technical Property Components of pro-Vitamin A Rice (GoldenRiceTM): A Preliminary Freedom-to-Operate Review (International Service for the Acquisition of Agri-biotech Applications, 2000).
and , ‘Investments in Pharmaceuticals before and after TRIPS’ (Working Paper, London Business School, 2008) 18, faculty.london.edu/mkyle/KM_TRIPS_081108.pdf at 2 March 2009.
and , ‘Indicators of the Relative Importance of IPRs in Developing Countries’ (Working Paper No 85, Queen Elizabeth House Working Paper Series, QEHWPS85, 2002).
, ‘Let's Overhaul the Pharmaceutical Benefits Scheme’, The Australian, 10 January 2006, 10.Google Scholar
, ‘Access to Medicines Has Been Improved’ (Geneva: The World Trade Organization), 9 December 2008, www.wto.org/english/news_e/sppl_e/sppl111_e.htm.
, ‘A New Global Patent Regime for Diseases: U.S. and International Legal Issues’ (2002) 16 Harvard Journal of Law and Technology85.Google Scholar
, ‘Depositing Seeds to Comply with the Patents Act 1990 (Cth) – The Adequacy of Definition and Description?’ (2004) 23 University of Tasmania Law Review68.Google Scholar
, ‘Patenting Genetic Diversity – Old Rules May Be Restricting the Exploitation of a New Technology’ (1999) 6 Journal of Law and Medicine373.Google Scholar
, ‘Patents and the CGIAR System of International Agricultural Research Centres’ Germplasm Collections under the International Treaty on Plant Genetic Resources for Food and Agriculture' (2004) 55 Australian Journal of Agricultural Research307.CrossRefGoogle Scholar
, ‘Regulating Access to Biological Resources: The Market Failure for Biodiversity Conservation’ (2006) 24 Law in Context137.Google Scholar
and , ‘Patenting Genetic Materials – Failing to Reflect the Value of Variation in DNA, RNA and Amino Acids’ (2000) 11 Australian Intellectual Property Journal69.Google Scholar
and , ‘The Evolution of the CBD's Development Agenda that May Influence the Interpretation and Development of TRIPS’, in and (eds.), Interpreting and Implementing the WTO Trade Related Agreement on Intellectual Property Rights: Is TRIPS Fair? (Cheltenham and Northampton, MA: Edward Elgar, 2008), 131.Google Scholar
, ‘Patent Opposition’, Lawyers Collective Affordable Medicines and Treatment Campaign, www.lawyerscollective.org/amtc/patent-opposition at 24 June 2009.
, ‘Enhancing Intellectual Property Exports through Fair Trade’, in and (eds.), Poor People's Knowledge: Promoting Intellectual Property in Developing Countries (Washington, DC: The World Bank, 2004), 75.Google Scholar
, ‘Access to HIV Drugs: Are We Changing the Two-World Paradigm?’ (2002) 17 Connecticut Journal of International Law281.Google ScholarPubMed
and , ‘Intellectual Property Protection and U.S. Foreign Direct Investment’ (1996) 78 The Review of Economics and Statistics181.CrossRefGoogle Scholar
and , ‘Avian and Pandemic Influenza: Progress and Problems with Global Health Governance’ (2007) 2 Global Public Health215.CrossRefGoogle ScholarPubMed
, ‘Ex Ante versus Ex Post Justifications for Intellectual Property’ (2004) 71 University of Chicago Law Review129.Google Scholar
, ‘Intellectual Property and Development at WHO and WIPO’ (2008) 34 American Journal of Law and Medicine257.CrossRefGoogle ScholarPubMed
, ‘150 Years of Patent Protection’ (Working Paper No 7478, National Bureau of Economic Research, 2001).
, and , ‘Cooperative Marketing Agreements between Competitors: Evidence from Patent Pools’ (Working Paper No 9680, National Bureau of Economic Research, 2003).
, ‘The New Court of Appeals for the Federal Circuit’ (1982) 64 Journal of the Patent and Trademark Office Society178.Google Scholar
and , Towards More Balanced, User-Friendly Paradigms in IP Law: A Project Reform of TRIPS (Special Session at the Annual Meeting of the International Association for the Advancement of Teaching and Research in Intellectual Property, 5 September 2006).
, , and , ‘Appropriating the Returns from Industrial Research and Development’ (1987) 18 Brookings Papers on Economic Activity783.CrossRefGoogle Scholar
and , ‘Regulatory Capture, Public Interest and Public Agenda: Toward a Synthesis’ (1990) 6 Journal of Law, Economics and Organization167.CrossRefGoogle Scholar
, and , ‘The Case for Public Funding and Public Oversight of Clinical Trials’ (2007) 4(1) The Economists' Voice article 3, 1.CrossRefGoogle Scholar
and , ‘Regional Trade Agreements under GATT 1994: An Exception and its Limits’, in (ed.), Challenges and Prospects for the WTO (London: Cameron May, 2005), 217.Google Scholar
, ‘Part II Proceedings Title: Combined discussion on the Statutory Resolution regarding disapproval of Patents (Amendment) Ordinance, 2004 (No 7 of 2004) (India) and the Patents (Amendment) Bill, 2005 (India)’, 22 March 2005, 164.100.24.230/Webdata/datalshom001/dailydeb/22032005.htm at 12 September 2008.
, ‘Measures to Enhance Access to Medical Technologies, and New Methods of Stimulating Medical R&D’ (2007) 40 University of California, Davis Law Review679.Google Scholar
‘Modeling Prize Fund Rewards’, Drug Development (With Access), 7 July 2006, www.cptech.org/blogs/drugdevelopment/2006/07/modeling-prize-fund-rewards.html at 20 February 2009.
‘Open Licensing vs Monopoly Controlled Supply’, Knowledge Ecology International (27 April 2008), www.keionline.org/component/option, com_jd-wp/Itemid,/p,112/ at 10 March 2009.
‘Proposal for an Essential Health Care Patent Pool’ (Paper presented at the XIV International AIDS Conference, Barcelona, 8 July 2002).
and , ‘The Big Idea: Prizes to Stimulate R&D for New Medicines’ (2007) 82 Chicago-Kent Law Review1519.Google Scholar
, International Economic Law (2nd edn, Oxford University Press, 2008).
and , ‘Strategic Pricing of New Pharmaceuticals’ (1998) 80 Review of Economics and Statistics108.CrossRefGoogle Scholar
and , Providing Protection for Plant Genetic Resources: Patents, Sui Generis Systems, and Biopartnerships (The Hague: Kluwer Law International, 2002).Google Scholar
, ‘Patents, Politics and Public Health: Access to Essential Medicines under the TRIPS Agreement’ (2006–7) 38 Ottawa Law Review191.Google Scholar
., ‘Challenges Confronting the Free Trade Area of the Americas’ (Canadian Foundation for the Americas Policy Paper, June 2002), www.focal.ca at 2 February 2009.
, ‘The Rise of the Regulatory State in Europe’ (1994) 17 West European Politics77.CrossRefGoogle Scholar
and , ‘In and Out of the Revolving Door: Making Sense of Regulatory Capture’ (1992) 12 Journal of Public Policy61.CrossRefGoogle Scholar
and (eds.), Interpreting and Implementing the WTO Trade Related Agreement on Intellectual Property Rights: Is TRIPS Fair? (Cheltenham and Northampton, MA: Edward Elgar, 2008).
and , ‘Innovation and Market Structure in the Dynamics of the Pharmaceutical Industry and Biotechnology: Towards a History Friendly Model’ (2002) 11 Industrial and Corporate Change667.CrossRefGoogle Scholar
, ‘Compulsory Licensing of Pharmaceutical Patents in Thailand’, Knowledge Ecology International (10 July 2007), www.keionline.org/misc-docs/thai/070710-PM-MoC.pdf at 20 March 2009.
, ‘Intellectual Property Protection, Foreign Direct Investment and Technology Transfer’ (Working Paper No 19, The World Bank, 1994).
and , ‘WHO IP and Health Group Concludes with Progress; Tough Issues Remain for Assembly’, Intellectual Property Watch (6 May 2008), www.ip-watch.org/ at 10 February 2009.
and , ‘WHO Members Inch toward Consensus on IP, Innovation and Public Health’ Intellectual Property Watch (2 May 2008), www.ip-watch.org/weblog/index.php?p=1024 at 10 February 2009.
, Seeing (RED): A Qualitative Analysis of the Product (RED) Campaign and Integration of Public Relations and Marketing Theory (Master of Mass Communication Thesis, Louisana State University, 2008).Google Scholar
, and , ‘Balancing Intellectual Monopoly Privileges and the Need for Essential Medicines’ (2007) 3(4) Globalization and Health, www.globalizationandhealth.com/content/3/1/4 at 22 June 2009.CrossRefGoogle ScholarPubMed
, ‘Intellectual Property Rights and Foreign Direct Investment’ (Policy Discussion Paper No 22, Centre for International Economic Studies, University of Adelaide, 2000).
Intellectual Property Rights in the Global Economy (Washington DC: Peterson Institute for International Economics, 2000).Google Scholar
Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries (Geneva: World Intellectual Property Organization, 2001).Google Scholar
‘Regulatory Standards in the WTO’ (Working Paper No WP00–1, Peterson Institute for International Economics, 2000).
‘The International Regulation of Intellectual Property’ (1998) 134 Review of World Economics186.Google Scholar
and , ‘The Globalisation of Private Knowledge Goods and the Privatisation of Global Public Goods’, in and (eds.), International Public Goods and Transfer of Technology under a Globalised Intellectual Property Regime (Cambridge University Press, 2005), 3.CrossRefGoogle Scholar
and (eds.), International Public Goods and Transfer of Technology under a Globalized Intellectual Property Regime (Cambridge University Press, 2005).CrossRef
, Regional Trade Agreements in the GATT/WTO: Article XXIV and the Internal Trade Requirement (The Hague: TMC Asser Press, 2002).CrossRefGoogle Scholar
, and (eds.), Health Partnerships Review: Focusing Collaborative Efforts on Research and Innovation for the Health of the Poor (Geneva: Global Forum for Health Research, 2008).
, ‘From the August 30, 2003 WTO Decision to the December 6, 2005 Agreement on an Amendment to TRIPS: Improving Access to Medicines in Developing Countries’ (2006) 2 Intellectual Property Quarterly91.Google Scholar
, ‘The Role of International NGOs in the Intellectual Property Policy-Making and Norm-Setting Activities of Multilateral Institutions’ (2007) 82 Chicago-Kent Law Review 1369.Google Scholar
, ‘WTO Decision on Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: A Solution to the Access to Essential Medicines Problem?’ (2004) 7 Journal of International Economic Law73.CrossRefGoogle Scholar
, ‘Choosing the Right Incentive Strategy for Research and Development in Neglected Diseases’ (2006) 84 Bulletin of the World Health Organization376.CrossRefGoogle ScholarPubMed
, ‘Open Source Drug Discovery: Finding a Niche (Or Maybe Several)’ (2007) 76 University of Missouri at Kansas City Law Review405.Google Scholar
, The Right Tool(s): Designing Cost-Effective Strategies for Neglected Disease Research (Report to the World Health Organization Commission on Intellectual Property Rights, Innovation and Public Health, 2005).
, and , ‘Finding Cures for Tropical Diseases: Is Open Source an Answer?’ (2004) 1 Public Library of Science, Medicine183.Google ScholarPubMed
, The World Intellectual Property Organization: Resurgence and the Development Agenda (New York and Oxford: Routledge, 2007).Google Scholar
, ‘The Global Campaign on Patents and Access to Medicines: An Oxfam Perspective’, in and (eds.), Global Intellectual Property Rights: Knowledge, Access and Development (Basingstoke: Palgrave Macmillan, 2002), 249.Google Scholar
, ‘Gates Foundation's Influence Criticized’, The New York Times, 16 February 2008.
, ‘Access to Essential Medicines: Can the World Health Organization Do More?’, 15 May 2001.
, ‘A Guide to the Post 2005 World: TRIPS, R&D and Access to Medicines’, 18 January 2005, www.msf.org/msfinternational/invoke.cfm?objectid=88694E5B-0FED-434A-A21EDA1006002653&component=toolkit.article&method=full_html.
, ‘Campaign for Access to Essential Medicines – Target Diseases: Tuberculosis’, accessible through the Internet Archive at web.archive.org/web/20071207071446, www.accessed-msf.org/campaign/tb01.shtm.
, Drug Patents under the Spotlight – Sharing Practical Knowledge about Pharmaceutical Patents (June 2004), www.who.int/3by5/en/patents_2003. pdf.
, ‘Generics and Access to Influenza Treatment’ (7 May 2009), www.msfaccess.org/main/access-patents/generics-and-access-to-influenza-treatment/.
, Neither Expeditious, nor a Solution: The WTO August 30th Decision Is Unworkable (August 2006), www.accessmed-msf.org/fileadmin/user_upload/medinnov_accesspatents/WTOaugustreport.pdf at 23 January 2009.
, and , Access to Medicine Index: Ranking Access to Medicine Practices (Haarlem: Access to Medicine Foundation, June 2008).Google Scholar
, ‘Resolving the Public Health Crisis in the Developing World: Problems and Barriers of Access to Essential Medicines’ (2007) 5 Northwestern University Journal of International Human Rights1.Google Scholar
, ‘TRIPS-Plus Provisions in FTAs; Recent Trends’, in and (eds.), Regional Trade Agreements and the WTO Legal System (Oxford: Oxford University Press, 2006), 215.CrossRefGoogle Scholar
, ‘Institutions for Intellectual Property Transactions: The Case of Patent Pools’, in , and (eds.), Expanding the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society (Oxford University Press, 2001), 123.Google Scholar
, ‘TRIPS and TRIPS-Plus Impacts in Africa’, in (ed.), Intellectual Property, Trade and Development (Oxford University Press, 2007), 259.Google Scholar
, ‘Socioeconomic Rights in Constitutional Law: Explaining America Away’ (2008) International Journal of Constitutional Law1.
, ‘Technology Licensing for the Benefit of the Developing World’ (2006) 18(2) Journal of Association of University Technology Managers19.Google Scholar
, ‘Patent Nonsense: Evidence Tells of an Industry Out of Social Control’ (2006) 175(4) Canadian Medical Association Journal374, www.cmaj.ca/cgi/content/full/175/4/374 at 20 April 2009.CrossRefGoogle ScholarPubMed
, ‘Opportunities for the Obama Administration and the G20 to Do Good for Global Health’ (2009) 2(2) Global Health Governance, www.ghgj.org/Volume%20II%20Issue%202.htm at 22 June 2009.Google Scholar
(ed.), Challenges and Prospects for the WTO (London: Cameron May, 2005).
and , ‘Patents and Public Health in the WTO, FTAs and Beyond: Tension and Conflict in International Law’ (2009) 43(3) Journal of World Trade571.Google Scholar
, ‘Is Public Domain Community Research Effective? The Nematode Caenorhabditis elegans as a Positive Case Study’ (Paper presented at Genomics and Intellectual Property: Considering Alternatives to Traditional Patenting, Vancouver, 9 March 2007).
, Virus: The Co-Discoverer of the Virus Tracks its Rampage and Charts its Future (New York: W. W. Norton and Co., 1999).Google Scholar
, , et al., ‘Human Immunodeficiency Viruses Associated with Acquired Immune Deficiency Syndrome (AIDS), a Diagnostic Method for AIDS and pre-AIDS, and a Kit Therefor’, United States Patent No: 4,708,818.
, Digital Code of Life: How Bioinformatics Is Revolutionizing Science, Medicine, and Business (Hoboken, NJ: John Wiley and Sons, 2004).Google Scholar
, ‘Medicines as Global Public Goods: The Governance of Technological Innovation in the New Era of Global Health’ (2009) 2(2) Global Health Governance, www.ghgj.org/Volume%20II%20Issue%202.htm at 22 June 2009.Google Scholar
, , , , , , , , , , , , , , , , , , , , , , , , and , ‘Health Innovation: The Neglected Capacity of Developing Countries to Address Neglected Diseases’ (2005) 309 Science401.CrossRefGoogle Scholar
and , An Introduction to Law and Regulation: Text and Materials (Cambridge University Press, 2007).CrossRefGoogle Scholar
, ‘Medicines for the Developing World: Promoting Access and Innovation in the Post-TRIPS Environment’ (2006) 64 University of Toronto Law Review45.Google Scholar
, , and , ‘The Growth of Patenting and Licensing by US Universities: An Assessment of the Effects of the Bayh-Dole Act of 1980’ (2001) 30 Research Policy99.CrossRefGoogle Scholar
, ‘Can Open-Source R&D Reinvigorate Drug Research’ (2006) 5 Nature Reviews Drug Discovery723.CrossRefGoogle ScholarPubMed
, and , Utilizing TRIPS Flexibilities for Public Health Protection through South–South Regional Frameworks (Geneva: South Centre, 2004).Google Scholar
(ed.), The Gaia Atlas of Future Worlds: Challenge and Opportunity in an Age of Change (New York: Anchor Books/Doubleday, 1990).
, , , ‘Letter to His Excellency Friedrich Hamburger’, 18 July 2007, www.actupparis.org/IMG/pdf/Answer_Thai.pdf at 20 March 2009.
and , ‘Request for a Compulsory License from KIPO on Behalf of People's Health Coalition for Equitable Society, Association of Physicians for Humanism, and Korean Pharmacists for Democratic Society’, glivec.jinbo.net/Request_for_CL_Final_version.htm at 5 September 2007.
, ‘Aligning Pharmaceutical Innovation with Medical Need’ (2007) 13 Nature Medicine304.CrossRefGoogle ScholarPubMed
, Changing Patterns of Pharmaceutical Innovation, May 2000, www.nihcm.org/~nihcmor/pdf/innovations.pdf at 20 April 2009.
, Philanthropy Quotes, www.nptrust.org/philanthropy/philanthropy_quotes.asp at 10 March 2009.
, ‘Uncertainty, Learning, and the Economics of Parallel Research and Development’ (1961) 43 Review of Economics and Statistics351.CrossRefGoogle Scholar
(ed.), The Development Agenda: Global Intellectual Property and Developing Countries (Oxford University Press, 2008).CrossRef
, ‘Lessons from Oregon’, in (ed.), Using Cost-Effective Analysis to Improve Health Care: Challenges and Opportunities (New York: Oxford University Press, 2004), 58–70.CrossRefGoogle Scholar
(ed.), Using Cost-Effective Analysis to Improve Health Care: Challenges and Opportunities (New York: Oxford University Press, 2004).CrossRef
, , , and , ‘Are Pharmaceuticals Cost-Effective? A Review of the Evidence’ (2000) 19 Health Affairs92.CrossRefGoogle Scholar
, John D. Rockefeller: The Heroic Age of American Enterprise (New York: C. Scribner & Sons, 1940).Google Scholar
and , ‘Technology Prizes for Climate Change Mitigation’ (Discussion Paper No 05–33, Resources for the Future, 2005).
and , ‘Cooperative Strategies for Facilitating Use of Patented Inventions in Biotechnology’ (2006) 24 Law in Context85.Google Scholar
and , ‘Pharmaceutical Patents and Developing Countries: The Conundrum of Access and Incentive’ (2002) 13 Australian Intellectual Property Journal21.Google Scholar
and , Open Source and Future of the Pharmaceutical Industry (2005) (on file with the author).
, ‘Can Article 5.7 of the WTO SPS Agreement Be a Model for the Precautionary Principle?’ (2007) 4 Script-ed367.Google Scholar
, ‘The Nobel Prize in Physiology or Medicine in 2008’, 6 October 2008, nobelprize.org/nobel_prizes/medicine/laureates/2008/press.html.
, ‘Open Source Biology’ (2007) 23 Santa Clara Computer and High Technology Law Journal271.Google Scholar
, Invention, Growth and Welfare: A Theoretical Treatment of Technological Change (Cambridge, MA: MIT Press, 1969).Google Scholar
, ‘Glivec Patent Case in India: Fact vs. Fiction’ (Press Release, not dated), www.novartis.com/downloads/about-novartis/facts-vs-fiction-india-glivec-patent-case.pdf at 27 March 2009.
‘Novartis Concerned that Indian Court Ruling Will Discourage Investments in Innovation Needed to Bring Better Medicines to Patients’ (Press Release, 6 August 2007), www.novartis.com/newsroom/news/index.shtml at 20 April 2009.
, ‘The HIV/AIDS Pandemic and Human Security’ (2006) 100 American Society of International Law Proceedings345.Google Scholar
, The Ethics of Patenting DNA: A Discussion Paper (2002).
and , ‘Curious Exceptions? Open Source Software and “Open” Technology’, in and (eds.), Handbook of Research on Open Source Software: Technological, Economic and Social Perspectives (New York: Information Science Reference, 2007), 227.Google Scholar
(ed.), Negotiating Trade: Developing Countries in the WTO and NAFTA (Cambridge University Press, 2006).CrossRef
and , ‘Reframing the Issue: The WTO Coalition on Intellectual Property and Public Health, 2001’, in (ed.), Negotiating Trade: Developing Countries in the WTO and NAFTA (Cambridge University Press, 2006).CrossRefGoogle Scholar
, and , ‘Patent Breadth, Patent Life and the Pace of Technological Progress’ (1998) 7 Journal of Economics and Management1.Google Scholar
, ‘Compulsory Licenses: Recent Experiences in Developing Countries’ (2006) 1 International Journal of Intellectual Property Management25.CrossRefGoogle Scholar
, ‘The International Relations of Intellectual Property: Narratives of Developing Country Participation in the Global Intellectual Property System’ (2003) 7 Singapore Journal of International and Comparative Law315.Google Scholar
, ‘Philippines Plans to Follow India in Limiting Patentability’, Managing Intellectual Property Weekly News (Hong Kong), 6 May 2008.Google Scholar
, ‘Crocodile Tears: How “TRIPS” Serves West's Monopoly’, The East African (Nairobi), 12 March 2001.Google Scholar
, ‘Patents, Essential Medicines, and the Innovation Game’ (2005) 58 Vanderbilt Law Review501.Google Scholar
, ‘Oprah and Bono Paint the Town Red’, The Oprah Winfrey Show, 13 October 2006, www.oprah.com/slideshow/world/globalissues/oprahshow3_ss_20061013 at 10 March 2009.
, ‘Should Access to Medicines and TRIPS Flexibilities Be Limited to Specific Diseases?’ (2008) 34 American Journal of Law and Medicine279.CrossRefGoogle ScholarPubMed
, ‘Ending the R&D Crisis in Public Health: Promoting Pro-Poor Medical Innovation’ (Briefing Paper No 122, Oxfam 2008).
‘Investing for Life: Meeting Poor People's Needs for Access to Medicines through Responsible Business Practices’ (Briefing Paper No 109, Oxfam, November 2007).
, ‘The Earth Summit: What Went Wrong at Rio?’ (1992) 70 Washington University Law Quarterly1005.Google Scholar
, The Earth Summit at Rio: Politics, Economics and the Environment (Boston, MA: Northeastern University Press, 1997).Google Scholar
, ‘Gates Foundation Follows New Paths: Giving Away $3 Billion a Year Is Not Easy as It Seems’, Seattle Post-Intelligencer, 24 June 2008.
., ‘Subsidiarity, Fragmentation and Democracy: Towards the Demise of General International Law?’, in and , (eds.) The Shifting Allocation of Authority in International Law (Oxford and Portland, ME: Hart Publishing, 2008) 193.Google Scholar
, ‘The Commodification of Medical and Health Care: The Moral Consequences of a Paradigm Shift from a Professional to a Market Ethic’ (1999) 24 Journal of Medicine and Philosophy243.CrossRefGoogle ScholarPubMed
, ‘An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments’ (1973) 81 Journal of Political Economy1049.CrossRefGoogle Scholar
and (eds.), Stones of Hope: How African Activists Reclaim Human Rights to Challenge Global Poverty (Palo Alto, CA: Stanford University Press, 2009).
and , ‘Freeing Mohammed Zakari: Footprints toward Hope’, in and (eds.), Stones of Hope: How African Activists Reclaim Human Rights to Challenge Global Poverty (Palo Alto, CA: Stanford University Press, 2009).Google Scholar
and , ‘The African Private Sector Steps in to Fill the Drug Gap’ (2007) 370 The Lancet722.CrossRefGoogle ScholarPubMed
and , ‘Study: Concerns on Mixing Plavix, Heartburn Drugs’, Associated Press, 11 November 2008, naturalhealthnews.blogspot.com/2008/11/plavix-and-nexium-combo-nixed.html at 15 April 2009.Google Scholar
, ‘Challenges to the Legitimacy and Efficiency of the World Trading System: Democratic Govenance and Competition Culture in the WTO’ (2004) 7 Journal of International Economic Law585.CrossRefGoogle Scholar
, ‘Orphan Drug Programs, Public–Private Partnerships and Current Efforts to Develop Treatments for Diseases of Poverty’ (2008) 4 Journal of Health and Biomedical Law19.Google Scholar
, Investor Statement and Framework on Pharmaceutical Companies and the Public Health Crisis in Emerging Markets (March 2003), 2.
‘Human Rights and Global Health: A Research Program’ (2005) 36 Metaphilosophy182.CrossRefGoogle Scholar
‘Relational Conceptions of Justice: Responsibilities for Health Outcomes’, in , and (eds.), Public Health, Ethics and Equity (Oxford: Oxford University Press, 2005).Google Scholar
, ‘Against Creative Capitalism’, Creative Capitalism – A Conversation, 26 June 2008, www.creativecapitalismblog.com/creative_capitalism/2008/06/against-creativ.html at 10 March 2009.
, ‘Disease Mongering Collection’ (2006) 3(4) Public Library of Science Medicine 191, colletions.plos.org/plosmedicine/diseasemongering-2006.php at February 2009.
and (eds.), The Political Economy of AIDS in Africa (Farnham: Ashgate Publishing, 2004) 19.
, ‘Proprietary Rights and Collective Action: The Case of Biotechnology Research with Low Commercial Value’, in and (eds.), International Public Goods and Transfer of Technology (Cambridge University Press, 2005) 288.Google Scholar
, ‘New Definition of “Patient Assistance Program” in Brazil’ (2005) 23(1) Healthy Skepticism International News, www.healthyskepticism.org/news/issue.php?id=7 at 11 July 2007.
, ‘Novartis Glitch with Glivec in Argentina?’, Essential Drugs.org, 15 May 2006 www.essentialdrugs.org/edrug/archive/200608/msg00070.php at February 2007.
, ‘Compliance and Effectiveness in International Regulatory Cooperation’ (2000) 32 Case Western Reserve Journal of International Law387.Google Scholar
, ‘Domestic Institutions and International Regulatory Cooperation: Comparative Responses to the Convention on Biological Diversity’ (1997) 49 World Politics482.CrossRefGoogle Scholar
, ‘Bono and Bobby Shriver Launch Product RED to Harness Power of the World's Iconic Brands to Fight AIDS in Africa’ (Press Release, 26 January 2006).
, ‘(RED) names Susan Smith Ellis as CEO’ (Press Release, 28 June 2007), joinred.com/news/pressrelease.asp?06282007.
, The Lazarus Effect (2007) YouTube www.youtube.com/watch?v=W82SoRp9Au4 at 10 March 2009.
, ‘From Free Riders to Fair Followers: Global Competition under the TRIPS Agreement’ (1997) 29 New York University Journal of International Law and Politics11.Google Scholar
, ‘Nurturing a Transnational System of Innovation’ (2007) 16 Journal of Transnational Law and Policy143.Google Scholar
and , ‘Harmonization without Consensus: Critical Reflections on Drafting a Substantive Patent Law Treaty’ (2007) 57 Duke Law Journal85.Google Scholar
and , ‘Non-Voluntary Licensing of Patented Inventions’ (Issue Paper No 5, United Nations Conference on Trade and Development – International Centre for Trade and Sustainable Development, 2003).
, ‘Novartis Files Case in India Challenging Patent Controller's Order and Patent Law’, Berne Declaration, 9 October 2006, www.evb.ch/en/p25011414.html#note1#note1 at 20 April 2009.
and , ‘Neglected Diseases and Well-Ordered Science’ (Technical Paper No 06/08, Centre for the Philosophy of Natural and Social Science Contingency and Dissent in Science, 2008).
, ‘The Wanderer: Bill Clinton's Quest to Save the World, Reclaim his Legacy and Elect his Wife’, The New Yorker, 18 September 2006.Google Scholar
and (2002) ‘Bioterrorism and Patent Rights: “Compulsory Licensure” and the case of Cipro’ (2002) 2(3) The American Journal of Bioethics29–39.CrossRefGoogle ScholarPubMed
, ‘Thailand Talking with Drug Firms – U.S. Chamber’, Reuters, 20 March 2007, lists.essential.org/pipermail/ip-health/2007-March/010800.html at 20 March 2009.
, ‘Thailand Will Override Cancer Drug Patents’, Reuters, 10 March 2008, www.reuters.com/article/healthNews/idUSBKK14764720080310 at 20 March 2009.
, and , ‘Developing Drugs for Developing Countries’ (2006) 25(2) Health Affairs313–24.CrossRefGoogle ScholarPubMed
, ‘A Submission to the Joint Standing Committee on Treaties: The Hong Kong Amendment to the TRIPs Agreement’ (Submission 2, 9 May 2007), works.bepress.com/matthew_rimmer/58/.
, ‘Beyond Blue Gene: Intellectual Property and Bioinformatics’ (2003) 34 International Review of Industrial Property and Copyright Law31.Google Scholar
, Intellectual Property and Biotechnology: Biological Inventions (Cheltenham and Northampton, MA: Edward Elgar, 2008).CrossRefGoogle Scholar
, ‘Race against Time: The Export of Essential Medicines to Rwanda’ (2008) 1 Public Health Ethics89.CrossRefGoogle Scholar
, ‘The Jean Chrétien Pledge to Africa Act: Patent Law and Humanitarian Aid’ (2005) 15 Expert Opinion on Therapeutic Patents889.CrossRefGoogle Scholar
, ‘The Race to Patent the SARS Virus: The TRIPS Agreement and Access to Essential Medicines’ (2004) 5 Melbourne Journal of International Law335.Google Scholar
, High Noon: 20 Global Problems, 20 Years to Solve Them (New York: Basic Books, 2002).Google Scholar
, and , ‘From Paris to Doha: The WTO Doha Declaration on the TRIPS Agreement and Public Health’, in and (eds.), Negotiating Health Intellectual Property and Access to Medicines (London: Earthscan Publications Ltd, 2006) 9.Google Scholar
, and (eds.), Negotiating Health Intellectual Property and Access to Medicines (London: Earthscan Publications Ltd, 2006).
, ‘The Patina of Philanthropy’, Stanford Social Innovation Review, 11 April 2007, www.ssireview.org/opinion/entry/the_patina_of_philanthropy/ at 10 March 2009.
, , , and , Demand Effects of Recent Changes in Prescription Drug Promotion (Kaiser Family Foundation, 2003).
, ‘Defending Economic, Social and Cultural Rights: Practical Considerations Faced by an International Human Rights Organization’ (2004) 26 Human Rights Quarterly63.CrossRefGoogle Scholar
, ‘(REDWASHING): Will Thousands of Red iPods, T-Shirts, and Cellphones Really Make the World a Better Place?’, Unlimited Magazine, 30 October 2007.
, ‘Toward a Theory of a Right to Health: Capability and Incompletely Theorized Agreements’ (2006) 18 Yale Journal of Law and Humanities273.Google Scholar
and , ‘The Global Role of the World Health Organisation’ (2009) 2(2) Global Health Governance, www.ghgj.org/Volume%20II%20Issue%202.htm at 22 June 2009.
. and , ‘Destabilization Rights: How Public Law Litigation Succeeds’ (2004) 117 Harvard Law Review 1016.CrossRefGoogle Scholar
, ‘Law's Legitimacy and “Democracy-Plus”’ (2006) 26 Oxford Journal of Legal Studies377.CrossRefGoogle Scholar
, Justice in Plainclothes: A Theory of American Constitutional Practice (New Haven, CT: Yale University Press, 2004).Google Scholar
, ‘IBM's Pragmatic Embrace of Open Source’ (2006) 49(10) Communications of the Association for Computing Machinery21.CrossRefGoogle Scholar
and , ‘WOLA's Human Rights Arguments against the Colombia FTA’ (Washington Office on Latin America, 7 April 2008), www.wola.org/ at 27 January 2009.
, ‘Collective Management of Intellectual Property – Patent Pools to Expand Access to Essential Medical Technologies’ (Research Note No 3(1), Knowledge Ecology International, 2007).
, ‘Intellectual Property Provisions in European Union Trade Agreements: Implications for Developing Countries’ (2007) United Nations Conference on Trade and Development – International Centre for Trade and Sustainable Development Issue Paper No 20, www.ictsd.org/pubs/index.htm at 27 January 2009.
and (eds.), Law and Globalization from Below: Towards a Cosmopolitan Legality (Cambridge University Press, 2005).CrossRef
and (eds.) Cause Lawyers and Social Movements (Palo Alto, CA: Stanford University Press, 2006).
, , , and , ‘Antibodies Reactive with Human T-lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS’ (1984) 224 Science506–8.CrossRefGoogle ScholarPubMed
, Governing in Europe: Effective and Democratic? (Oxford University Press, 1999).CrossRefGoogle Scholar
, ‘Open Source Biotechnology: A Drug for Developing Countries’ Health Problems' (10 May 2007) Social Sciences Research Network, papers.ssrn.com/sol3/papers.cfm?abstract_id=1130798 at 3 March 2009.
‘Markets and Uncertainty in Pharmaceutical Development’ (Working Paper No RWP07–039, John F. Kennedy School of Government, Harvard University, 2007).
and , ‘Post-TRIPS Options for Access to Patented Medicines in Developing Nations’ (2002) 5 Journal of International Economic Law913.CrossRefGoogle Scholar
., Buddhist Economics, The E.F. Schumacher Society, www.schumachersociety.org/buddhist_economics/english.html at 26 February 2009.
, ‘New Cipro Source Could Dramatically Increase Supply’ (Press Release, 16 October 2001), www.senate.gov/~schumer/SchumerWebsite/pressroom/press_releases/PR00728.html at 2 March 2009.
, , , , and , ‘Serological Analysis of a Subgroup of Human T-lymphotropic Retroviruses (HTLV-III) Associated with AIDS’ (1984) 224 Science503–5.CrossRefGoogle ScholarPubMed
, ‘Letter to Congressman Thomas Allen’, 17 January 2008.
, ‘Standing on the Shoulders of Giants: Cumulative Research and the Patent Law’ (1991) 5 Journal of Economic Perspectives29.CrossRefGoogle Scholar
, ‘Analysing Regulatory Space: Fragmented Resources and Institutional Design’ (2001) Public Law329.Google Scholar
, , and , ‘Towards Mutual Trust, Transparency and Equity in Virus Sharing Mechanism: The Avian Influenza Case of Indonesia’ (2008) 37 Annals Academy of Medicine Singapore482.Google ScholarPubMed
, ‘Industry Strategies for Intellectual Property and Trade: The Quest for TRIPS, and Post-TRIPS Strategies’ (2002) 10 Cardozo Journal of International and Comparative Law79.Google Scholar
‘Intellectual Property Protection and Antitrust in the Developing World: Crisis, Coercion, and Choice’ (1995) 49 International Organization315.CrossRefGoogle Scholar
Power and Ideas: The North–South Politics of Intellectual Property and Antitrust (Albany, NY: State University of New York Press, 1998).Google Scholar
Private Power, Public Law: The Globalization of Intellectual Property Rights (Cambridge University Press, 2003).CrossRefGoogle Scholar
and , ‘Using Ideas Strategically: The Contest between Business and NGO Networks in Intellectual Property Rights’ (2004) 48 International Studies Quarterly143.CrossRefGoogle Scholar
, ‘Survey of Patent Pools Demonstrates Variety of Purposes and Management Structures’ (Research Note No 6, Knowledge Ecology International, 2007).
, ‘Policy Space for Development in the WTO and Beyond: The Case of Intellectual Property Rights’ (Working Paper No 05/06, Global Development and Environment Institute, Tufts University, 2005).
, , and , ‘Global Trade and Public Health’ (2005) 95 American Journal of Public Health23.CrossRefGoogle ScholarPubMed
, Defending Interests: Public Private Partnerships in W.T.O.Litigation (Washington, DC: Brookings Institution Press, 2003).Google Scholar
, ‘Navigating the Patent Thicket: Cross Licences, Patent Pools and Standard-Setting’, in , , and (eds.), Innovation Policy and the Economy, Vol. 1 (Cambridge, MA: MIT Press, 2001).Google Scholar
, Who Guards the Guardians?: Judicial Control of Administration (Athens, GA: University of Georgia Press, 1988).Google Scholar
, ‘Key Issues Unresolved at WHO Meeting on Influenza Virus Sharing’, Third World Network (2008), www.twnside.org.sg/title2/health.info/2008/twnhealthinfo20081201.htm at 6 March 2009.
‘More Countries Use Compulsory License, but New Problems Emerge’, Third World Network (19 May 2005), www.twnside.org.sg/title2/health.info/twninfohealth004.htm.
and , ‘Rewards versus Intellectual Property Rights’ (2001) 44 Journal of Law and Economics525.CrossRefGoogle Scholar
, Basic Rights: Subsistence, Affluence and U.S. Foreign Policy (2nd edn, Princeton University Press, 1996).Google Scholar
, ‘India's Gleevec Ruling Is Bad News for Other Drugmakers Too’ Pharmalot, 7 August 2007, www.pharmalot.com/2007/08/indias-gleevec-ruling-is-bad-news-for-other-drugmakers-too/ at 4 October 2007.
, , and , ‘Managing Severe Acute Respiratory Syndrome (SARS) Intellectual Property Rights: The Possible Role of Patent Pooling’ (2005) 83 Bulletin of the World Health Organization707.Google ScholarPubMed
, The Vienna Convention on the Law of Treaties (2nd edn, Manchester University Press, 1984).Google Scholar
, ‘What a Billionaire Should Give – and What Should You?’, New York Times Magazine, 17 December 2006.
, ‘Patents v. Patients: AIDS, TNCs and Drug Price Wars’, Third World Network (2001), www.twnside.org.sg/title/twr131c.htm at 11 July 2007.
, ‘How Do Foreign Patent Rights Affect U.S. Exports, Affiliate Sales, and Licenses?’ (2001) 55 Journal of International Economics411.CrossRefGoogle Scholar
and , ‘The Marginal Welfare Cost of Public Funds: Theory and Estimates’ (1996) 61 Journal of Public Economics289.CrossRefGoogle Scholar
, ‘The Olde Order Crumbleth: HIV-Pestilence as a Security Issue and New Thinking about Core Concepts in International Affairs’ (2003) 13 Indiana International and Comparative Law Review481.Google Scholar
, ‘The RED Brigade’, Promo Magazine, 1 January 2007.
, ‘Improving Access to Essential Medicines: How Health Concerns can be Prioritised in the Global Governance System’ (2008) 1 Public Health Ethics83.CrossRefGoogle ScholarPubMed
, and , ‘Are Existing Governance Structures Equipped to Deal with Today's Global Health Challenges? Towards Systematic Coherence in Scaling Up’ (2009) 2(2) Global Health Governance, www.ghgj.org/Volume%20II%20Issue%202.htm at 22 June 2009.Google Scholar
, ‘Intellectual Property Rights and Bio Commons: Open Source and Beyond’ (2006) 58(188) International Social Science Journal319.CrossRefGoogle Scholar
, ‘Sink or Swim: Eco-Patent Commons and Transfer of Environmentally Sustainable Technologies’ (2008) 2(2) Bridges Trade BioRes17.Google Scholar
, ‘Intellectual Property Rights, Innovation and Healthcare: Unanswered Questions in Theory and Policy’ (2008) 10(2) Economica (Rio de Janeiro) 106.Google Scholar
and (eds.), Handbook of Research on Open Source Software: Technological, Economic and Social Perspectives (New York: Information Science Reference, 2007).
, ‘3 Billion Cedis Voted for Medical Bills’, Daily Graphic (Ghana), 29 January 2003.
, ‘First Generic Drugs En Route to Africa under 5-Year-Old WTO Deal’ (2008) 12(31) Bridges Weekly Trade News Digest5.Google Scholar
, ‘The Culture of the WTO: Why it Needs to Change’ (2007) 10 Journal of International Economic Law483.CrossRefGoogle Scholar
, ‘Judicial Lawmaking at the WTO: Discursive Constitutional and Political Constraints’ (2004) 98 American Journal of International Law247.CrossRefGoogle Scholar
, ‘Knowledge as a Global Public Good’, in , and (eds.), Global Public Goods: International Cooperation in the 21st Century (New York: Oxford University Press, 1999), 306.Google Scholar
, ‘Scrooge and Intellectual Property Rights: A Medical Prize Fund Could Improve the Financing of Drug Innovations’ (2006) 333 British Medical Journal1279.CrossRefGoogle Scholar
and , ‘Drug Maker's Vow to Donate Cancer Medicine Falls Short’, The New York Times, 5 June 2003.
, ‘The AIDS Crisis, Differential Pricing of Drugs, and the TRIPS Agreement’ (2001) 4 Journal of World Intellectual Property323.CrossRefGoogle Scholar
, ‘Novartis Loses Patent Claim on Cancer Drug – Patents Controller Upholds Natco Contention’, The Hindu Business Line, 26 January 2006.
, The Second Bill of Rights: FDR's Unfinished Revolution and Why We Need It More than Ever (New York: Basic Books, 2004).Google Scholar
and , ‘Property Rights Issues Involving Plant Genetic Resources: Implications of Ownership for Economic Efficiency’ (2000) 32 Ecological Economics75.CrossRefGoogle Scholar
, ‘Should a Prize System for Pharmaceuticals Require Patent Protection for Eligibility?’, Discussion Paper Number 2, www. healthimpactfund.org.
, ‘Presentation at the Royal Institute of International Affairs’, London, 14 March 2002).
, ‘Report of the Commission on Intellectual Property Rights, Innovation and Public Health: A Call to Governments’ (2006) 84 Bulletin of the World Health Organization421.CrossRefGoogle Scholar
, The Global Politics of Pharmaceutical Monopoly Power: Drug Patents, Access, Innovation and the Application of the WTO Doha Declaration on TRIPS and Public Health (Diemen: AMB Publishers, 2009).Google Scholar
, ‘TRIPS, Pharmaceutical Patents and Access to Essential Medicines: A Long Way from Seattle to Doha’ (2002) 3 Chicago Journal of International Law27.Google ScholarPubMed
and , Wikinomics: How Mass Collaboration Changes Everything (New York: Portfolio, Penguin Books, 2006).Google Scholar
, ‘Rethinking TRIPS: “Adequate Remuneration” for Non-Voluntary Patent Licensing’ (2008) 11(4) Journal of International Economic Law927–70.CrossRefGoogle Scholar
, ‘Saving the Village: Conserving Jurisprudential Diversity in the International Protection of Traditional Knowledge’, in and (eds.) International Public Goods and Transfer of Technology under a Globalised Intellectual Property Regime (Cambridge University Press, 2005), 521.CrossRefGoogle Scholar
, Taking your Medicine: Drug Regulation in the United States (Cambridge, MA: Harvard University Press, 1980).CrossRefGoogle Scholar
, Big Shot: Passion, Politics and the Struggle for an AIDS Vaccine (New York: Public Affairs, 2001).Google Scholar
and , ‘The SNP Consortium Website: Past, Present and Future’ (2003) 31 Nucleic Acids Research124–7.CrossRefGoogle ScholarPubMed
, ‘Saving the Blueprints: The International Legal Regime for Plant Resources’ (1998) 30 Case Western Reserve Journal of International Law373.Google Scholar
, ‘International Trade: Regionalism’, in and (eds.), Research Handbook in International Economic Law (Cheltenham: Edward Elgar, 2007), 151.Google Scholar
, ‘Regulatory Jurisdiction and the WTO’ (2007) 10 Journal of International Economic Law631.CrossRefGoogle Scholar
, ‘The Constitutions of the WTO’ (2006) 17 European Journal of International Law623.CrossRefGoogle Scholar
, ‘Treating Desires Not Diseases: A Pill for Every Ill and an Ill for Every Pill?’ (2007) 12 Drug Discovery Today161.CrossRefGoogle Scholar
, , , , and , ‘Drug Development for Neglected Diseases: A Deficient Market and a Public-Health Policy Failure’ (2002) 359 The Lancet2188.CrossRefGoogle Scholar
and , The Rise and Fall of Fast Track Trade Authority, (Washington, DC: Public Citizen's Global Trade Watch, 2008), www.citizen.org/documents/riseandfall.pdf at 27 January 2009.
and , ‘Compulsory Drug Licenses Violate World Trade Treaty’, Bangkok Post, 23 April 2007.
, ‘Thailand: 20 More Drugs in Pipeline for Possible Compulsory Licences’, Intellectual Property Watch, 2 November 2007, www.ip-watch.org/ at 11 February 2009.
, Weak Courts, Strong Rights: Judicial Review and Social Welfare Rights in Comparative Constitutional Law (Princeton University Press, 2008).Google Scholar
and , ‘Patent-Busting: Punishing the Poor’, The Straits Times (Singapore), 2 May 2008.Google Scholar
, ‘Reconciling Patent Policies and University Mission’ (2006) 13 Ethical Perspectives234.Google Scholar
, , and , ‘Models for Facilitating Access to Patents on Genetic Inventions’ (2006) 7 Nature Reviews Genetics143.CrossRefGoogle ScholarPubMed
, , , , and , ‘Grand Challenges in Global Health’ (2003) 302 Science398.CrossRefGoogle ScholarPubMed
, ‘US–Peru Trade Deal: The First Test of Renegotiated IP Provisions’, Intellectual Property Watch, 5 November 2007, www.ip-watch.org at 23 January 2009.
and (eds.), Intellectual Property Law in the New Millennium (Cambridge University Press, 2004).CrossRef
, ‘MSF Intervention at IGWG 2.2’, 2008, www.accessmed-msf.org/msf-intervention-at-igwg-22/.
, Access to Biological Resources in Commonwealth Areas (Canberra: The Commonwealth, 2000).Google Scholar
, ‘Biomedical Philanthropy: State of the Donation’ (2007) 447 Nature248.CrossRefGoogle ScholarPubMed
, ‘Keeping the WTO from Becoming the “World Trans-science Organization”: Scientific Uncertainty, Science Policy and Fact Finding in the Growth Hormones Dispute’ (1981) 31 Cornell International Law Journal251.Google Scholar
, ‘Our Statements: Majority of House Democrats Stand Up for Constituents’, Public Citizens, 8 November 2007, citizen.typepad.com/eyesontrade/2007/11/our-statement-m.html at 3 February 2009.
, Celebrities, Culture and Cyberspace: The Light on the Hill in a Postmodern World (Sydney: Pluto Press, 1999).Google Scholar
, Measuring Legal Implementation of International Human Rights Norms in the Context of HIV/AIDS (Canberra: ANU College of Law, 2001).Google Scholar
, ‘Legitimate Actors? The Future Roles for NGOs against HIV/AIDS in Sub-Saharan Africa’, in and (eds.), The Political Economy of AIDS in Africa (Farnham: Ashgate Publishing, 2004) 19.Google Scholar
, ‘Should Prizes Replace Patents? A Critique of the Medical Innovation Prize Act of 2005’ (2007) 13 Boston University Journal of Science and Technology Law25.Google Scholar
and , ‘A Human Rights Approach to Intellectual Property Protection: The Genesis and Application of Sub-Commission Resolution 2000/7’ (2003) 5 Minnesota Intellectual Property Review1.Google Scholar
and , ‘How Do Intellectual Property Law and International Trade Agreements Affect Access to Antiretroviral Therapy’ (2006) 3(8) The Public Library of Science Medicine1230–6.Google ScholarPubMed
, ‘The Impact of Regulation of Pharmaceutical Research Expenditures: A Dynamic Approach’ (1983) 21 Economic Inquiry115.CrossRefGoogle ScholarPubMed
, ‘Market Segmentation: Techniques, Actors and Incentives – The Use of Intellectual Property Rights’ (Paper presented at the Workshop on Differential Pricing and Financing of Essential Drugs, WHO and WTO Secretariats, Norway, 8–11 April 2001).
, ‘Bono and Hirst Paint the Town Red: Rock Star Bono and Artist Damien Hirst Teamed Up and Raised $42.5M for Africa’, ABC News, 15 February 2008.
, ‘The Role of Science in the Uruguay Round and NAFTA Trade Disciplines’ (1994) 27 Cornell International Law Journal817.Google Scholar
, ‘Big Pharma as a Catalyst for Change’, Harvard Medical School, 13 February 2009, www.gsk.com/media/Witty-Harvard-Speech-Summary.pdf.
, ‘Decision-Making and Transparency in the ‘Medieval’ WTO: Does the Sutherland Report Have the Right Prescription?’ (2005) 8 Journal of International Economic Law631.CrossRefGoogle Scholar
, ‘Thailand Issues More Compulsory Drug Licenses’, Reuters (25 January 2007), lists.essential.org/pipermail/ip-health/2007-January/010433.html at 20 March 2009.
, Corporate Social Responsibility: Making Good Business Sense (Geneva and Washington, DC: World Business Council for Sustainable Development, 2000).Google Scholar
, ‘Punk Rock Capitalism’, New Internationalist, 11 January 2006, www.encyclopedia.com/doc/1G1–155174516.html at 10 March 2009.
, ‘The Economics of Invention Incentives: Patents, Prizes, and Research Contracts’ (1983) 73 American Economic Review691.Google Scholar
. ‘Critical Race Praxis: Race Theory and Political Lawyering Practice in Post-Civil Rights America’ (1997) 95 Michigan Law Review821.CrossRefGoogle Scholar
, ‘Not Just a Tragedy: Access to Medications as a Right under International Law’ (2003) 21 Boston University International Law Journal325.Google ScholarPubMed
, ‘Who's Giving Money to Bill Clinton?’, Los Angeles Times, 4 October 2007.
, ‘Access to Medicines, BRICS Alliances and Collective Action’ (2008) 34 American Journal of Law and Medicine345.CrossRefGoogle ScholarPubMed
, ‘Pyrimidine Derivatives and Processes for the Preparation Thereof’, U.S. Patent No 5,521,184 (filed 28 April 1994; issued 28 May 1996).
Abigail Alliance for Better Access to Developmental Drugs v. C. Von Eschenbach, 495 F 3d 695 (DC Cir. 2007).
Actavis UK Ltd v. Merck & Co. Inc., [2008] EWCA Civ 444.
AIDS Access Foundation et al. v. Bristol-Myers Squibb Company and Department of Intellectual Property, Central Intellectual Property & International Trade Court, Black Case No Tor Por 34/2544, Red Case No 92/2545 (Thailand 2002).
Anheuser-Busch Inc. v. Portugal, (10 October 2005) App No 73049/01 Eur Court HR.
Apotex Inc. v. Sanofi-Synthelabo Canada Inc., [2008] 3 S.C.R. 265.
Apotex Inc. v. Wellcome Foundation Ltd, [2002] 4 S.C.R. 153.
Bandhua Mukti Morcha v. Union of India, (AIR 1984 SC 802).
Cadbury Limited, [2002] ATMO 56 (28 June 2002).
Cadbury Schweppes Pty Ltd v. Darrell Lea Chocolate Shops Pty Ltd (No 4), [2006] FCA 446.
Cadbury Schweppes Pty Ltd v. Darrell Lea Chocolate Shops Pty Ltd (No 8), [2008] FCA 470.
Consumer Project on Technology, ‘Statement of Information to the Competition Commission of South Afria on Complaint against GlaxoSmithKline and Boehringer Ingelheim’ (3 February 2003), www.cptech.org/ip/health/cl/cl-cases/rsa-tac/cptech-statement.doc.
Cruz Bermude, et al. v. Ministerio de Sanidad y Asistencia Social, (Case No 15.789, Decision No 916, 15 July 1999).
Darrell Lea Chocolate Shops Pty Ltd v. Cadbury Limited, [2008] ATMO 6 (15 January 2008).
Dawson Chemical Company v. Rohm & Haas, 448 US 176 (1980).
Farooque v. Bangladesh & Ors, (Writ Petition No 92 of 1996).
First National Bank of SA Ltd t/a Wesbank v. Commissioner, South African Revenue Service, 2002 (4) SA 768 (CC).
Google, Inc. v. Microsoft Corp., 415 F Supp 2d 1018 ND Cal 2005.
Hazel Tau & Others v. GlaxoSmithKline and Boehringer Ingelheim, Competition Commission of South Africa (2003).
Hoffmann v. South African Airways, 2001 (1) SA 1 (CC, South Africa).
In re Masucci, 179 USPQ 829 (TTAB 1973).
The Initiative for Medicines, Access & Knowledge (I-MAK) v. Abbott Laboratories, Indian Patent Application No 339/MUM/2006 filed on 23 August 2004, 16 August 2007.
Kasikili/Sedudu Island (Botswana v. Namibia) (Judgment), [1999] ICJ Rep 1045, 1075–6.
Madey v. Duke University, 307 F 3d 1351 (Fed Cir, 2002).
Mendoza and Ors v. Minister of Public Health and the Director of the National AIDS-HIV-STI Programme, (Resolucion No 0749–2003-RA, 28 January 2004).
Merck KGAA v. Integra Lifesciences I, Inc., 545 U.S. 193 (2005).
Microsoft Corporation, [2007] ADO 1 (14 February 2007).
Microsoft Corporation v. PC Club Australia Pty Ltd, [2005] FCA 1522.
Minister of Health v. Treatment Action Campaign, 2002 (5) SA 721.
Network of Positive People, and the Indian Network for People Living With HIV/AIDS v. Abbott Laboratories, Indian Application No IN/PCT/2001/01312/MUM, 4 August 2006, www.i-mak.org/storage/PgOppKaletraSoftGel.pdf.
Novartis AG and another v. Union of India and others, (6 August 2007, High Court of Judicature at Madras for W.P. Nos. 24759 and 24760 of 2006), judis.nic.in/chennai/qrydisp.asp?tfnm=11121.
Novartis v. Union of India (6 August 2007), Order of High Court of Judicature at Madras for W.P. Nos. 24759 and 24760 of 2006), (Affidavit filed by Petitioner Novartis), www.cptech.org/ip/health/c/india/novartis-v-india.doc at 23 September 2007.
Novartis v. Union of India (6 August 2007), Order of High Court of Judicature at Madras for W.P. Nos. 24759 and 24760 of 2006), (Affidavit in Reply filed by the Respondent).
Novartis v. Union of India (6 August 2007), Order of High Court of Judicature at Madras for W.P. Nos. 24759 and 24760 of 2006), (The Novartis petition challenging the rejection of Glivec patent claim), www.scribd.com/doc/456550/High-Court-order-Novartis-Union-of-India.
Paschim Banga Khet Mazdoor Society v. State of West Bengal (AIR 1996 SC 2426).
The Pharmaceutical Manufacturers' Association of South Africa v. Government of South Africa, Notice of Motion, Case Number 4183/98, in the High Court of South Africa (Transvaal Provincial Division).
The Pharmaceutical Manufacturers' Association of South Africa v. Government of South Africa, Case Number 4183/98, in the High Court of South Africa (Transvaal Provincial Division), paras. 58–71 Founding Affidavit, ‘Application to be admitted as an amicus curiae’.
President of the Republic of South Africa v. Modderklip Boerdery (Pty) Ltd, 2005 (5) SA 3 (CC).
Qualitex Co. v. Jacobson Products Co., Inc., 514 US 159 (1995).
Roche Products, Inc. v. Bolar Pharmaceutical Co., 733 F 2d 858 (Fed Cir, 1984).
Samity v. State of W.B., (1996) 4 S.C.C. 37 (Sup. Ct. India).
Soobramoney v. Minister of Health, Kwazulu-Natal, 1998 (1) SA 765 (‘Soobramoney’).
State of Punjab v. Mahindrasingh Chawla, (AIR 1997 SC 1225).
Woolworths Limited v. BP [2006] FCAFC 132.
Z4 Technologies, Inc. v. Microsoft Corp., 507 F 3d 1340 CA Fed (Tex) (2007).
An Act to Amend the Patent Act and the Food and Drugs Act (Canada), SC 2004, c. 23 (‘The Jean Chrétien Pledge to Africa Act’).
An Act to amend the Public Health Service Act to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in a terrorist attack against the United States by giving the National Institutes of Health contracting flexibility, infrastructure improvements, and expediting the scientific peer review process, and streamlining the Food and Drug Administration approval process of countermeasures (Project Bioshield Act) 2004 (United States) Pub L No 108-276 (2004), codified in 42 USC § 2001.
Constitution of the Republic of Ghana 1992.
Constitution of the Republic of India 1950.
Constitution of the Republic of South Africa 1996.
Constitution of the United States of America 1787.
Drug Price Competition and Patent Term Restoration Act 1984 (United States), Pub L No 98-417, 98 Stat. 1585 (1984), codified in 21 USC § 355, 360 (2000), 35 USC § 156, 271, 282 (2000) (‘the Hatch-Waxman Act’).
Executive Order 13155 of 10 May 2000 (United States), ‘Access to HIV/AIDS Pharmaceuticals and Medical Technologies’, www.archives.gov/federal-register/executive-orders/2000.html.
Federal Act on Cartels and Other Restraints on Competition of 6 October 1995 (Switzerland).
Federal Food, Drug, and Cosmetic Act 2008 (United States) 21 USC § 355.
Food and Drug Administration Amendments Act 2007 (United States) 21 USC § 301 (2007).
Hospital Fees Act 1971 (Ghana).
Intellectual Property Code 1997 (The Philippines) [Republic Act No 8293].
Medical Innovation Prize Fund Act 2007 (United States) (S. 2210).
Medicare Prescription Drug Improvement and Modernization Act 2003 (United States) Pub L No 108-173, 117 Stat. 2066 (2003).
Medicines and Related Substances Act 101 of 1965 (South Africa).
Medicines and Related Substances Control Amendment Act 1997 (South Africa).
National Health Act 1953 (Cth).
Patent Act 1952 (United States) 35 USC § 1.
Patent Act 1979 (Thailand) B.E. 2522.
The Patent Reform Act 2007 (United States) (H.R. 1908, S. 1145).
Patents Act 1970 (India).
Patents Act 1990 (Cth).
Patents Amendment Act 2002 (India).
Patents (Amendment) Act 2005 (India).
Patents (Amendment) Ordinance 2004 (No 7 of 2004) (India).
Rules of the Constitutional Court of South Africa 2003 (South Africa).
Trade Act 1974 (United States) 19 USC § 2102 (1974).
Trade Act 2002 (United States) 19 USC § 3801 (2002).
Trade Promotion Authority Act 2002 (United States), title XXI of Pub L No 107-210 (2002), div. B, Aug. 6, 2002, 116 Stat. 993, codified in 19 USC § 3805.
Trademark Act 1946 (United States) (‘Lanham Act’), 15 USC § 1052 (1946).
Universally Accessible Cheaper and Quality Medicines Act 2008 (the Philippines).
University and Small Business Patent Procedures Act 1980 (United States) (the ‘Bayh-Dole Act’) 35 USC § 200–12 (1980).
, Integrating Intellectual Property Rights and Development Policy (2002), www.iprcommission.org/ at 5 February 2009.
. Protocol Amending the TRIPS Agreement, (Canberra: Australian Parliament, August 2007), www.aph.gov.au/house/committee/jsct/9may2007/report/chapter9.pdf.Google Scholar
, ‘Oslo Ministerial Declaration – Global Health: A Pressing Foreign Policy Issue of our Time’ (2007) 369 The Lancet1373.CrossRefGoogle Scholar
, ‘Announcement Regarding Exploitation of Patents on Drugs and Medical Supplies for Clopidogrel’ (Press Release, 25 January 2007), www.cptech.org/ip/health/c/thailand/thai-cl-clopidogrel_en.pdf at 20 March 2009.
, Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand (16 February 2007) www.moph.go.th/hot/White%20Paper%20CL-EN.pdf at 31 March 2009 (‘Thai White Paper’).
, Bringing Hope: Supplying ARVs for HIV/AIDS Treatment: The United States President's Emergency Plan for AIDS Relief (Washington DC: United States Department of State, May 2006), www.state.gov/documents/organization/66513.pdf at 23 August 2008.Google Scholar
, Keeping Science Open: The Effects of Intellectual Property Policy on the Conduct of Science (London: The Royal Society of the United Kingdom, 2003).Google Scholar
, Increasing People's Access to Essential Medicine in Developing Countries: A Framework for Good Practice in the Pharmaceutical Industry (March 2005), www.dfid.gov.uk/Pubs/files/pharm-framework.pdf at 18 May 2009.
, ‘Declaration Made at the United Nations Environment Programme Conference for the Adoption of the Agreed Text of the Convention on Biological Diversity’ (1992) 31 International Legal Materials848.Google Scholar
, Australia–U.S. Medicines Working Group Holds First Meeting (24 October 2007), www.globalhealth.gov/news/news/011406.html at 23 February 2009.
, ‘Letter from Joel Klein to Carey Ramos’ (10 June 1999) (‘Toshiba Review Letter’).
,‘Letter from Joel Klein to Gerrard Beeney’ (26 June 1997) (‘MPEG-LA Review Letter’).
, ‘Letter from Joel Klein to Gerrard Beeney’ (16 December 1998) (‘Sony Review Letter’).
, Antitrust Enforcement and Intellectual Property Rights: Promoting Innovation and Competition (2007), www.usdoj.gov/atr/public/hearings/ip/222655.pdf at 2 March 2009.
Antitrust Guidelines for the Licensing of Intellectual Property (1995).
, ‘Convention on Biological Diversity’ (1992) 3 US Department of State Dispatches423.
, CDER NDAs Approved in Calendar Years 1990–2004 by Therapeutic Potential and Chemical Type (2008), www.fda.gov/cder/rdmt/pstable.htm at 19 February 2009.
, International Trade – An Analysis of Free Trade Agreements and Congressional and Private Sector Consultations under Trade Promotion Authority (November 2007), www.gao.gov/new.items/d0859.pdf at 27 January 2009.
, Trade Agreements and Access to Medications under the Bush Administration (June 2005), www.reform.house.gov/ at 27 January 2009.
, ‘Biotech Group Explain Objection to Earth Summit's Biodiversity Treaty’ (1992) 44 Patent, Trademark and Copyright Journal120.Google Scholar
Trademark Manual of Examining Procedure: Fifth Edition (Alexandria, VA: United States Patent and Trade Mark Office, 2007).Google Scholar
, Special 301 Report (30 April 2007) www.ustr.gov/Document_Library/Press_Releases/2007/April/SPECIAL_301_Report.html at 20 March 2009.
‘United States Files WTO Cases against China over Deficiencies in China's Intellectual Property Rights Laws and Market Access Barriers to Copyright-Based Industries’ (Press Release, 9 April 2007).
Africa – The African Proposal for the establishment of a Development Agenda for WIPO (Inter-Sessional Intergovernmental Meeting on a Development Agenda for WIPO, 3rd sess, 20–22 July 2005) (IMM/3/2 Rev), www.wipo.int/edocs/mdocs/mdocs/en/iim_3/iim_3_2_rev.doc at 19 May 2009.
, Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/C/W/401 (2003) (Communication from the African, Caribbean and Pacific Group of States).
,African Charter on Human and Peoples' Rights, OAU Doc. CAB/LEG/67/3 rev. 5; 1520 UNTS 217; 21 ILM 58 (1982).
Agreement between the World Intellectual Property Organization and the World Trade Organization, WIPO Doc WO030 (22 December 1995), www.wipo.int/treaties/en/agreement/pdf/trtdocs_wo030.pdf at 16 January 2009.
Amendment of the TRIPS Agreement, WTO Doc WT/L/641 (2005) (Decision of 6 December 2005 of the General Council) (‘TRIPS Waiver’).
Amendment of the TRIPS Agreement – Extension of the Period for the Acceptance by Members of the Protocol Amending the TRIPS Agreement, WTO Doc WT/L/711 (2007) (Decision of the General Council of 18 December 2007).
Amendment of the TRIPS Agreement: Proposal for a Decision on an Extension of the Period for the Acceptance by Members of the Protocol Amending the TRIPS Agreement, WTO Doc IP/C/45 (2007).
Application of the International Health Regulations (2005), World Health Assembly 59th mtg Res WHA59.2 (2006).
Arbitration Rules of the United Nations Commission on International Trade Law, GA Res 31/98, UN GAOR, 31st sess, 99th plen mtg, UN Doc A/Res/31/98 (1976).
and , Proposal by Argentina and Brazil for the Establishment of a Development Agenda for WIPO, 31st (15th extraordinary) sess, WIPO Doc WO/GA/31/11 Add (27 August 2004).
Australia–United States Free Trade Agreement (AUSFTA), signed 18 May 2004 (entered into force 1 January 2005).
Bahrain–United States Free Trade Agreement, signed 14 September 2004 (entered into force 4 August 2006).
Berne Convention for the Protection of Literary and Artistic Works, opened for signature 9 September 1886, 1161 UNTS 3 (entered into force 29 January 1970).
Brazil – Measures Affecting Patent Protection, WT/DS199/4, G/L/454, IP/D/23/Add.1, 19 July 2001, (01–3506).
Canada – Notification under Paragraph 2(C) of the Decision of 30 August 2003 on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/N/10/CAN/1 (2007).
Canada – Patent Protection of Pharmaceutical Products: Arbitration under Article 21.3(c) of the Understanding on Rules and Procedures Governing the Settlement of Disputes, WTO Doc WT/DS114/R (2000) (Award of the Arbitrator James Bacchus) (‘Canada – Pharmaceuticals’).
Canada – Patent Protection of Pharmaceutical Products, WTO Doc WT/DS114/R (2000) (Report of the Panel) (‘Canada – Pharmaceutical Patents’).
Canada – Term of Patent Protection, WTO Doc WT/DS170/AB/R, AB-2000–7 (2000) (Report of the Appellate Body).
Central American Free Trade Agreement–Dominican Republic Free Trade Agreement, signed 5 August 2004 (entered into force between the United States and El Salvador on 1 March 2006, followed by Honduras and Nicaragua on 1 April 2006, Guatemala on 1 July 2006, and the Dominican Republic on 1 March 2007. The remaining partner country, Costa Rica, approved the agreement in a national public referendum on 7 October 2007, although entry into force is pending passage of necessary implementation legislation by the Costa Rican legislature).
, ‘Opening Remarks at the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property’, (Geneva: World Health Organization, 28 April 2008).
Chile – IPEG Survey on Copyright Limitations and Exceptions: Preliminary Report on Copyright Limitations and Exceptions, APEC Doc 2008/SOM1/IPEG/007 (2008).
Chile – Provisional Committee on proposals related to a WIPO Development Agenda (1st sess, 20–24 February, 2006): Proposal by Chile (PCDA/1/2), www.wipo.int/edocs/mdocs/mdocs/en/pcda_1_2.doc at 19 May 2009.
Chile–United States Free Trade Agreement, signed 6 June 2003 (entered into force 1 January 2004).
China – Measures Affecting the Protection and Enforcement of Intellectual Property Rights, WTO Doc WT/DS362/R (2008) (Report of the Panel).
China – Measures Affecting the Protection and Enforcement of Intellectual Property Rights, WT/DS362/R (26 January 2009).
China – Measures Affecting Trading Rights and Distribution Services for Certain Publications and Audiovisual Entertainment Products, WTO Doc WT/DS363 (2008).
Colombia – Provisional Committee on proposals related to a WIPO Development Agenda (1st sess, 20–24 February 2006): Proposal by Colombia (PCDA/1/3), www.wipo.int/edocs/mdocs/mdocs/en/pcda_1/pcda_1_3.doc at 19 May 2009.
Colombia–United States Free Trade Agreement, signed 22 November 2006 (pending US Congress approval).
Commission Notice: Guidelines on the Application of Article 81 of the EC Treaty to Technology Transfer Agreements [2004] OJ C 101/2.
, Public Health, Innovation and Intellectual Property Rights (Geneva: World Health Organization, 2006).Google Scholar
, Revised Draft Report, 2nd sess, WIPO Doc CDIP/2/4 Prov. 2 (2008).
The Committee on the Judiciary, United States Congress, The Patent Reform Act of 2007: Report Together with Additional and Minority Views (to Accompany S. 1145), Report No 110–259 (2008).
Compilation of General Comments and General Recommendations Adopted by Human Rights Treaty Bodies, 127, UN Doc HRI/GEN/1/Rev.6 (2003).
, Access to Genetic Resources and Benefit Sharing: Legislation, Administrative and Policy Information, 2nd mtg, UN Doc No UNEP/CBD/COP/2/13 (1995) (Report by the Secretariat).
, Access to Genetic Resources, 3rd mtg, UN Doc UNEP/CBD/COP/3/20 (1996) (Note by the Executive Secretary).
, The Relationship between the TRIPS Agreement and the Convention on Biological Diversity – Summary of Issues Raised and Points Made – Submission by the WTO Secretariat, 8th mtg, UN Doc UNEP/CBD/COP/8/INF/37 (2006).
, Report of the Conference of the Parties to the CBD on the Work of its Ninth Meeting, 9th mtg, UN Doc UNEP/CBD/COP/9/29 (2008).
, Report of the Eighth Meeting of the Parties to the Convention on Biological Diversity, 8th mtg, UNEP/CBD/COP/8/31 (2006).
, Report of the Seventh Meeting of the Conference of the Parties to the Convention on Biological Diversity, 7th mtg, UNEP/CBD/COP/7/21 (2004).
, Report of the Sixth Meeting of the Conference of the Parties to the Convention on Biological Diversity, 6th mtg, annex 1 (Decisions Adopted by the Conference of the Parties to the Convention on Biological Diversity at its Sixth Meeting), VI/24(A) (Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing of the Benefits Arising out of their Utilization) UN Doc UNEP/CBD/COP/6/20 (2002) (‘Bonn Guidelines’).
, Review of National, Regional and Sectoral Measures and Guidelines for Implementation of Article 15, 4th mtg, UN Doc UNEP/CBD/COP/4/23 (1998).
, Research and Development in the Pharmaceutical Industry (Washington, DC: Congressional Budget Office, 2006).Google Scholar
Convention on Biological Diversity, opened for signature 5 June 1992, [1993] ATS 32 (entered into force 29 December 1993).
Convention Establishing the World Intellectual Property Organization, opened for signature 14 July 1967, 848 UNTS 3 (entered into force 26 April 1970) (‘WIPO Convention’).
Convention on the Elimination of Discrimination against Women, GA Res 34/180, 34 UN GAOR Supp (No 46) at 193, UN Doc A/34/46, entered into force 3 September 1981.
Convention on the Grant of European Patents, opened for signature 5 October 1973, 13 ILM 268 (entered into force 7 October 1977) (‘European Patent Convention’).
Convention on the Rights of the Child, GA Res 44/25, annex, 44 UN GAOR Supp (No 49) at 167, UN Doc A/44/49 (1989), entered into force 2 September 1990.
, Instrument of Acceptance, SGS7/16652 (Brussels, 19 November 2007), www.wto.org/english/tratop_e/trips_e/popup_amendment_ec_e.htm.
, The Relationship between the TRIPS Agreement and the Convention on Biological Diversity: Summary of Issues Raised and Points Made, UN Doc IP/C/W/368/Rev.1/Corr.1 (2006) (Note by the Secretariat, Corrigendum).
Decision on Differential and More Favourable Treatment, Reciprocity, and Fuller Participation of Developing Countries, GATT BISD 26S/203, GATT Doc L/4903 (28 November 1979) (‘Enabling Clause’).
Declaration on the TRIPS Agreement and Public Health: Adopted on 14 November 2001, WTO Doc WT/MIN(01)/DEC/2 (2001) (‘the Doha Declaration’).
Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the Legal Protection of Databases [1996] OJ L 077.
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use [2001] OJ L 311.
Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 [2004] OJ L 136.
Doha Work Programme, Ministerial Conference 6th sess, WTO Doc WT/MIN(05)/DEC (2005) [40] (Ministerial Declaration).
Draft Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property, WIPO Doc A/PHI/IGWG/2/INF.DOC./6 (31 August 2007) (Intergovernmental Working Group on Public Health, Innovation and Intellectual Property – Provisional Agenda Item 3).
, ECOWAS Member States, www.ecowas.int/ at 23 April 2009.
Revised Treaty, WTO Doc WT/COMTD/N/21 (2005) (Notification from the Parties to the Agreement).
EU Parliament Resolution of 12 July 2007 on TRIPS Agreement and access to medicines, P6_TA(2007) 0353, [I], www.europarl.europa.eu/ at 20 March 2009.
EU Regulation 141/2000 of the European Parliament and of the Council of 16 December 1999 on Orphan Medicinal Products, [2000] OJ L 18.
European Communities – Measures Affecting the Approval and Marketing of Biotech Products, WTO Doc WT/DS291/R, WT/DS292/R, WT/DS293/R (2006) (Reports of the Panel).
European Communities – Measures Concerning Meat and Products (Hormones), WTO Doc WT/DS26/R, WT/DS26/AB/R, WT/DS48/R, WT/DS48/AB/R (1998) (Reports of the Panel and Appellate Body).
European Communities – Protection of Trademarks and Geographic Indications for Agricultural Products and Foodstuffs, WTO Doc WT/DS174/R (2005) (Report of the Panel) (‘EC – GI’).
European Communities – Trade Description of Sardines, WTO Doc WT/DS231/AB/R, AB-2002–3 (2002) (Report of the Appellate Body).
, Global Status and Trends in Intellectual Property Claims: Genomics, Proteomics and Biotechnology, Ad Hoc Open-Ended Working Group on Access and Benefit-Sharing 3rd mtg, 32–52, UN Doc UNEP/CBD/WG-ABS/3/INF/4 (2005) (Submission by the European Community).
Extension of the Transition Period under Article 66.1 for Least-Developed Country Members, WTO Doc IP/C/40 (2005) (Decision of the Council for TRIPS of 29 November 2005).
Extension of the Transition Period under Article 66.1 of the TRIPS Agreement for Least-Developed Country Members for Certain Obligations with Respect to Pharmaceutical Products, WTO Doc IP/C/25 (2005) (Decision by the Council for TRIPS of 27 June 2002).
The Friends of Development, ‘Proposal to Establish a Development Agenda for WIPO: An Elaboration of Issues Raised in Document WO/GA/31/11’, Inter-Sessional Intergovernmental Meeting on a Development Agenda for WIPO, IIM/1/4 (6 April 2005).
General Agreement on Tariffs and Trade 1994, www.wto.org/english/res_e/booksp_e/analytic_index_e/gatt1994_e.htm.
Geneva Declaration on the Future of the World Intellectual Property Organization 2004, www.cptech.org/ip/wipo/futureofwipodeclaration.pdf at 5 February 2009.
Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property, World Health Assembly 61st mtg, Res WHA61.21 (2008) (‘WHO Global Strategy’).
The Implementation of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/C/W/402 (2003) (Communications by the European Communities and their Member States).
Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc WT/L/540 (2003) (WTO General Council Decision of 30 August 2003).
India – Patent Protection for Pharmaceutical and Agricultural Chemical Products, WTO Doc WT/DS50/AB/R, AB-1997–5 (1997) (Report of the Appellate Body) (‘India – Pharmaceuticals’).
, Sharing of Influenza Viruses and Access to Vaccines and Other Benefits: Interdisciplinary Working Group on Pandemic Influenza Preparedness, WHO Doc A/PIP/IGM/5 (2007), annex (Fundamental Principles and Elements for the Development of a New System for Virus Access and Fair and Equitable Benefit Sharing Arising from the Use of the Virus for the Pandemic Influenza Preparedness) (Proposal by Indonesia).
, Mapping of Intellectual Property Related to the Production of Pandemic Influenza Vaccines (Geneva: World Health Organization, 2007).Google Scholar
Intellectual Property Rights, Innovation and Public Health, World Health Assembly 56th mtg, Res WHA56.27 (2003).
, Sharing of Influenza Viruses and Access to Vaccines and Other Benefits: Interdisciplinary Working Group on Pandemic Influenza Preparedness, WHO Doc A/PIP/IGM/4 (2007) (Report by the Director-General).
International Covenant on Civil and Political Rights, GA Res 2200A (XXI), 21 UN GAOR Supp (No 16) at 52, UN Doc A/6316 (1966), 999 UNTS 171, entered into force 23 March 1976.
International Covenant on Economic, Social and Cultural Rights, opened for signature 16 December 1966, 993 UNTS 3 (entered into force 3 January 1976).
Israel–United States Free Trade Agreement, signed 22 April 1985 (entered into force 1 September 1985).
Japan – Measures Affecting Agricultural Products, WTO Doc WT/DS76/AB/R, AB-1998–8 (1999) (Report of the Appellate Body).
Japan – Measures Affecting the Importation of Apples, WTO Doc WT/DS245/R, WT/DS245/AB/R, (2003) (Report of the Panel).
Jordan–United States Free Trade Agreement, signed 24 October 2000 (entered into force 17 December 2001).
Least-Developed Country Members – Obligations under Article 70.9 of the TRIPS Agreement with Respect to Pharmaceutical Products, WTO Doc WT/L/478 (2002) (Decision of the General Council of 8 July 2002).
, Patent Issues Related to Influenza Viruses and their Genes: An Overview (2007), www.who.int/csr/disease/avian_influenza/WIPO_IP_%20paper19_10_2007.pdf at 8 March 2009.
, Report of the High-Level Task Force on the Implementation of the Right to Development on its Second Meeting, UN Doc E/CN.4/2005/WG.18/TF/3 (2005).
Marrakesh Agreement Establishing the World Trade Organization, opened for signature 15 April 1994, 1867 UNTS 3 (entered into force 1 January 1995) (‘Marrakesh Agreement’).
Marrakesh Agreement Establishing the World Trade Organization, opened for signature 15 April 1994, 1867 UNTS 3 (entered into force 1 January 1995), annex 1A (Agreement on Technical Barriers to Trade) (‘TBT’).
Marrakesh Agreement Establishing the World Trade Organization, opened for signature 15 April 1994, 1867 UNTS 3, annex 1A (Agreement on the Application of Sanitary and Phytosanitary Measures) (entered into force 1 January 1995) (‘SPS Agreement’).
Marrakesh Agreement Establishing the World Trade Organization, opened for signature 15 April 1994, 1867 UNTS 3, annex 1C (Agreement on Trade-Related Aspects of Intellectual Property Rights) (entered into force 1 January 1995) (‘TRIPS Agreement’).
Marrakesh Agreement Establishing the World Trade Organization, opened for signature 15 April 1994, 1867 UNTS 3, annex 2 (Understanding on Rules and Procedures Governing the Settlement of Disputes) (entered into force 1 January 1995) (‘DSU’).
Ministerial Declaration: Adopted on 14 November 2001, WTO Doc WT/MIN(01)/DEC/1 (2001).
Morocco–United States Free Trade Agreement, signed 15 June 2004 (entered into force 1 January 2006).
, Specific Human Rights Issues – Human Rights and the Human Genome: Interim Report Submitted by the Special Rapporteur, UN Doc E/CN.4/Sub.2/2005/38 (2005).
Negotiating Group on Trade-Related Aspects of Intellectual Property Rights, Including Trade in Counterfeit Goods, Status of Work in the Negotiating Group: Chairman's Report to the GNG, GATT Doc MTN.GNG/NG11/W/76 (23 July 1990).
Negotiations on Improvements and Clarifications of the Dispute Settlement Understanding: Further Contribution of the United States on Improving Flexibility and Member Control in WTO Dispute Settlement, WTO Doc TN/DS/W/82/Add.1 (2005) (Communication from the United States).
, The Impact of the International Patent System on Developing Countries, WIPO Doc A/39/13 Add.3 (2003) (Report presented to the WIPO under terms of a Special Service Agreement).
North American Free Trade Agreement, signed 17 December 1992 (entered into force 1 January 1994).
Oman–United States Free Trade Agreement, signed 19 January 2006 (entered into force 1 January 2009).
, Report on Progress to Date, WHO Doc A/PIP/IGM/WG/5 (2008).
, Genetic Inventions, Intellectual Property Rights and Licensing Practices: Evidence and Policies (Berlin: Organisation for Economic Co-operation and Development, 2002).Google Scholar
Harnessing Markets for Biodiversity: Towards Conservation and Sustainable Use (Berlin: Organisation for Economic Co-operation and Development, 2003).Google Scholar
‘Short Summary Report of the Workshop on Genetic Inventions, Intellectual Property Rights and Licensing Practices’ (Berlin, 24–25 January 2002), www.oecd.org/ at 9 February 2009.
Panama–US Trade Promotion Agreement, signed 28 June 2007 (pending US Congress approval).
Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, World Health Assembly 60th mtg, Res WHA60.28 (2007).
Paris Convention for the Protection of Industrial Property, opened for signature 20 March 1883, 21 UST 1583 (entered into force 26 April 1970) (‘Paris Convention’).
Peru–United States Trade Promotion Agreement, signed 14 December 2007 (entered into force 1 February 2009).
, , On the Report of the Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health, Mr Paul Hunt, (A/HRC/7/11 dated 31 January 2008) (7th Session of the HRC, 12 March 2008).
Proposed Thailand–United States Free Trade Agreement, www.cptech.org/ip/health/c/thailand/us-thai-fta.html at 20 March 2009.
Protocol on Trade in the Southern African Development Community, WTO Doc WT/REG176/N/1/Rev.1 (2004) (Notification by Tanzania – Revision).
Public Health, Innovation, Essential Health Research and Intellectual Property Rights: Towards a Global Strategy and Plan of Action, 59th sess, WHA Res 59.24, apps.who.int/gb/ebwha/pdf_files/WHA59/A59_R24-en.pdf.
Report of the United Nations Conference on the Environment and Development, annex 1 (Rio Declaration on Environment and Development), UN Doc A/CONF 151/26 (Vol I) (1992).
The Republic of Korea–United States Free Trade Agreement (KORUSFTA), signed 30 June 2007 (pending US Congress approval).
Request for a Compulsory License from KIPO to Grant a Compulsory License for Registered Patent No 261366 (Glivec patent) in Accordance with Article 107(1)(iii) of the Korean Patent Law (30 January 2002), glivec.jinbo.net/Request_for_CL_Final_version.htm at 20 April 2009.
Revision of the International Health Regulations, World Health Assembly 58th mtg, Res WHA58.3 (2005).
Rwanda – Notification under Paragraph 2(A) of the Decision of 30 August 2003 on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/N/9/RWA/1 (2007).
, Pre-Pandemic and Pandemic Influenza Vaccines: Scientific Evidence Base (Department of Health, UK, 2008), www.dh.gov.uk at 6 March 2009.Google Scholar
, Handbook of the Convention on Biological Diversity (2nd edn, Montreal: Secretariat of the Convention on Biological Diversity, 2003).Google Scholar
, Trade and Environment at the WTO (Geneva: World Trade Organization, 2004), www.wto.org/english/res_e/trade-env_e.pdf at 6 March 2009.Google Scholar
Singapore–United States Free Trade Agreement, signed 6 May 2003 (entered into force 1 January 2004).
, Background to the Free Trade Area, www.sadc.int/fta/index/browse/page/57 at 23 April 2009.
, Report on the International Patent System, 12th sess, WIPO Doc SCP/12/3 (2008) www.wipo.int/edocs/mdocs/scp/en/scp_12/scp_12_3.pdf at 19 January 2008.
Strengthening Pandemic-Influenza Preparedness and Response, World Health Assembly 58th mtg, Res WHA58.5 (2005).
, UNDP Millennium Development Goals: Goal 8, www.undp.org/mdg/goal8.shtml at 19 May 2009.
, ‘Eighth Board Meeting: UNITAID Moves toward a Patent Pool for Medicines’ (Geneva, 2–3 July 2008), www.unitaid.eu/en/Eighth-Board-Meeting-Geneva-2–3-July-2008.html at 10 March 2009.
, ‘UNITAID Moves toward a Patent Pool for Medicines’, www.unitaid.eu/en/NEWS/UNITAID-moves-towards-a-patent-pool-for-medicines.html at 10 March 2009.
, Fragmentation of International Law: Difficulties Arising from the Diversification and Expansion of International Law, UN Doc A/CN.4/L.682 (13 April 2006) (‘Koskenniemi Report’).
, Report 03 Human and Income Poverty: Developing Countries, Population Living Below $2 a Day (%) (2007–8), hdrstats.undp.org/indicators/24.html at 2 March 2009.
, Report of the High Commissioner – The Impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights on Human Rights, UN Doc E/CN.4/Sub.2/2001/13 (2001).
, ‘Fifth Committee Approves Assessment Scale for Regular, Peacekeeping Budgets, Text on Common System, Pension Fund, as it Concludes Session’ (Press Release, 22 December 2006).
, Conserving Indigenous Knowledge: Integrating New Systems of Integration (United Nations Development Programme, 1994).Google Scholar
, General Comment No 14: The Right to the Highest Attainable Standard of Health (Article 12 of the International Covenant on Economic, Social and Cultural Rights) ¶ 33, UN Doc E/C.12/2004 (11 August 2000).
, Report of the Ad Hoc Working Group on the Work of the Second Session in Preparation for a Legal Instrument on Biological Diversity, 7, UN Doc UNEP/BioDiv2/3 (1990).
United States – Omnibus Appropriations Act of 1998, WTO Doc WT/DS176/AB/R, AB-2001–7 (2001) (Report of the Appellate Body).
United States – Section 110(5) of US Copyright Act: Request for the Establishment of a Panel by the European Communities and their Member States, WTO Doc WT/DS160/R, 70 (2000) (‘US – 110(5)’).
United States – Standards for Reformulated and Conventional Gasoline, WTO Doc WT/DS2/AB/R, AB-1996–1 (20 May 1996) (Report of the Appellate Body).
Universal Declaration of Human Rights, GA Res. 217A (III), UN Doc A/810 (1948).
Vienna Convention on the Law of Treaties, opened for signature 22 May 1969, 1155 UNTS 331 (entered into force 27 January 1980).
Working Document – Barbados and Bolivia: Proposal 6: Clinical Trials on Medicines as Global Public Goods (2008), www.keionline.org/misc-docs/b_b_igwg/prop6_clinical_trials_as_as_global_public_goods.pdf at 4 March 2009.
, Battling HIV/AIDS: A Decision Maker's Guide to the Procurement of Medicines and Related Supplies (Washington, DC: The World Bank, 2004).Google Scholar
, Financing Health Services in Developing Countries: An Agenda for Reform (Washington, DC: The World Bank, 1987).Google Scholar
, Global Economic Prospects and the Developing Countries (Washington, DC: The World Bank, 2001), siteresources.worldbank.org/INTGEP2002/Resources/gep2002complete.pdf at 6 February 2009.Google Scholar
, Global Economic Prospects: Technology Diffusion in the Developing World (Washington, DC: The World Bank, 2008), siteresources.worldbank.org/INTGEP2008/Resources/complete-report.pdf at 5 February 2009.Google Scholar
, Intellectual Property: Balancing Incentives with Competitive Access (2001), 128, siteresources.worldbank.org/INTGEP2002/Resources/gep2002complete.pdf at 23 April 2009.
, Avian and Pandemic Influenza: Best Practice for Sharing Influenza Viruses and Sequence Data, 60th World Health Assembly, WHO Doc A60/INF.DOC./1 (2007) (Report by the Secretariat).
, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, 61st mtg, WHO Doc A61/4 (2008) (Report by the Secretariat).
, Report of the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property, 61st mtg, WHO Doc A61/9 (2008).
, A Summary of Tracking Avian Influenza A (H5N1) Specimens and Viruses Shared with WHO from 2003 to 2007 (Geneva: World Health Organization, 2008).Google Scholar
, ‘AIDS Medicine and Diagnostic Services’ (2003), www.who.int/3by5/publications/briefs/amds/en/index.html at 16 August 2006.
, Avian and Pandemic Influenza: Developments, Response and Follow-Up, and Application of the International Health Regulations (2005): Best Practice for Sharing Influenza Viruses and Sequence Data, Executive Board 120th sess, WHO Doc EB120/INF.DOC./3 (2007) (Report by the Secretariat).
, Chair's Text – Draft – Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, WHO Doc A/PIP/IGM/WG/6 (2008).
, Draft Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property, Intergovernmental Working Group on Public Health, Innovation, and Intellectual Property (3 May 2008) www.who.int/phi/documents/IGWG_Outcome_document03Maypm.pdf (‘Draft Global Strategy’).
, Equitable Access to Essential Medicines: A Framework for Collective Action (2004), whqlibdoc.who.int/hq/2004/WHO_EM_2004.4.pdf.
, Essential Medicines Model List (Revised April 2002), www.who.int/medicines/organization/par/edl/eml.shtml at 23 July 2003.
, Essential Medicines Model List (15th list, March 2007), www.who.int/medicines/publications/08_ENGLISH_indexFINAL_EML15.pdf at 29 April 2009.
, Global Pandemic Influenza Action Plan to Increase Vaccine Supply, WHO Doc WHO/IVB/06.13, WHO/CDS/EPR/GIP/2006.1 (2006).
, Globalization, TRIPS and Access to Pharmaceuticals: WHO Policy Perspectives on Medicines, No 3, WHO Doc WHO/EDM/2001.2 (March 2001).
, Guidelines for Implementing the Bamako Initiative (Geneva: World Health Organization, 1988).Google Scholar
, ‘Influenza A (H1N1)’, www.who. int/csr/disease/swineflu/en/index.html at 18 June 2009.
, ‘Member States’ Comments and Inputs to the IGWG 2 Conference Paper', A/PHI/IGWG/2/Conf.Paper1/Rev.1 (Geneva: World Health Organization, January 2008), www.who.int/phi/submissions/submissions_confpaper/en/index.html.
, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, Executive Board 124th sess, WHO Doc EB124/4 (2008) (Report by the Secretariat).
, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits – Intergovernmental Meeting: Report of Progress to Date, Executive Board 122nd sess, WHO Doc EB122/5 (2008) annex 5 (Interim Statement of the Intergovernmental Meeting on Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccine and Other Benefits).
, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits – Intergovernmental Meeting: Report of Progress to Date, Executive Board 122nd sess, WHO Doc EB122/5 (2008) annex 6 (Consolidated Outcome Text: Index).
, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, Open Ended Working Group, Chair's Text Draft – Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, WHO Doc A/PIP/IGM/WG/6 (2008).
, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, Patent Issues Related to Influenza Viruses and their Genes, WHO Doc A/PIP/IGM/3 (2007) (Report by the Director-General).
, Public Health, Innovation and Intellectual Property (Geneva: World Health Organization, 2008), www.who.int/phi/en/ at 23 February 2009.Google Scholar
, Report on Developments Since the First Session of the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property, Summary of the Second Hearing, A/PHI/IGWG/2/INF.DOC./4, (Geneva: World Health Organization, 2 November 2007), www.who.int/gb/phi/pdf/igwg2/PHI_IGWG2_ID4-en.pdf.
, Reports by the Director-General: Summary Progress Reports, WHO Doc A/PIP/IGM/2 Rev.1 (2007).
, Reports by the Director-General: Summary Progress Reports – WHO Influenza Virus Traceability Mechanism, WHO Doc A/PIP/IGM/9 (2008).
, Reports of the Director-General: Establishment of the Advisory Mechanism, WHO Doc A/PIP/IGM/8 (2008).
, The Global Burden of Disease: 2004 Update (Geneva: World Health Organization, 2004), www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html.Google Scholar
, ‘World Health Assembly Closes: Agreement Reached on Influenza Virus Sharing, Intellectual Property’ (Geneva: World Health Organization, 23 May 2007).
, World Health Report 2004 – Changing History (Geneva: World Health Organization, 2004), www.who.int/csr/disease/avian_influenza/TrackingHistoryH5N1_20080131.pdf at 6 March 2009.Google Scholar
, Background Document for the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG) Process (Geneva: World Health Organization, 2007).Google Scholar
, Macroeconomics and Health: Investing in Health for Economic Development (Geneva: World Health Organization, 2001).Google Scholar
, Scaling Up the Response to Infectious Diseases – A Way Out of Poverty (Geneva: World Health Organization, 2002).Google Scholar
World Health Organization Constitution 1946.
, Advice on Flexibilities under the TRIPS Agreement, www.wipo.int/ip-development/en/legislative_assistance/advice_trips.html at 16 January 2009.
, Agenda for Development of the International Patent System, WIPO Doc A/36/14 (6 August 2001).
, Development Agenda, www.wipo.int/ip-development/en/agenda/.
, Draft Agenda, Provisional Committee on Proposals Related to a WIPO Development Agenda, 4th sess, WIPO Doc PCDA/4/1 Prov. (2007) (‘PCDA’).
, Patent Agenda: Options for Development of the International Patent System, WIPO Doc A/37/6 (19 August 2002).
, Patent Agenda: Options for Development of the International Patent System, WIPO Doc A/37/6 (2002), annex I (Memorandum of the Director-General).
, Striking a Balance: Patents and Access to Drugs and Health Care (Geneva, World Intellectual Property Organization), www.wipo.int/export/sites/www/freepublications/en/patents/491/wipo_pub_491.pdf at 5 February 2009.
, Accessions: Republic of Liberia, www.wto.org/english/thewto_e/acc_e/a1_liberia_e.htm at 23 April 2009.
, Annual Report (2006) of the Council for TRIPS, WTO Doc IP/C/44 (2006).
, Annual Review of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/C/33 (2004) (Report to the General Council).
, Annual Review of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/C/37 (2005) (Report to the General Council).
, Annual Review of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/C/42 (2006) (Report to the General Council).
, Annual Review of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/C/46 (2007) (Report to the General Council).
, Factual Presentation – Protocol on Trade in the Southern African Development Community (SADC): Report by the Secretariat, WTO Doc WT/REG176/4 (2007) (Report by the Secretariat).
, Members Accepting Amendment of the TRIPS Agreement, www.wto.org/english/tratop_e/trips_e/amendment_e.htm at 23 April 2009.
, Members and Observers, www.wto.org/english/thewto_e/whatis_e/tif_e/org6_e.htm at 23 April 2009.
, ‘Members OK Amendment to Make Health Flexibility Permanent’, (Press Release, 6 December 2005), www.wto.org/english/news_e/pres05_e/pr426_e.htm.
, Minutes of Meeting Held in the Centre William Rappard on 25, 26 and 30 August 2003, WTO Doc WT/GC/M/82 (13 November 2003).
, Minutes of Meeting Held in the Centre William Rappard on 28 August 2003, WTO Doc IP/C/M/41 (7 November 2003) (Council for TRIPS).
, Notifications by Exporting WTO Members, www.wto.org/english/tratop_e/trips_e/public_health_notif_export_e.htm at 23 April 2009.
, Notifications by Importing WTO Members, www.wto.org/english/tratop_e/trips_e/public_health_notif_import_e.htm at 23 April 2009.
, Protocol Amending the TRIPS Agreement – Status of Acceptances, WTO Doc IP/C/W/490/Rev.1 (2007) (Note from the Secretariat – Revision).
, Regional Trade Agreements Notified to the GATT/WTO and in Force: A–Z Table, www.wto.org/english/tratop_e/region_e/a_z_e.xls at 23 April 2009.